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SOX3 is a transcription factor found within neural progenitor cells (NPC) of the 
developing and adult vertebrate central nervous system. SOX3 is also found in 
other tissues, most notably the spermatogonial progenitor/stem cell populations in 
the testes. Normal brain development in both humans and mice, and sperm 
production in mice, is reliant on the correct expression and dosage of SOX3. The 
function of SOX3 has been explored through a number of different cell and mouse 
model based techniques, however, the mechanisms through which SOX3 acts 
remain largely unknown.   
This thesis explores the genome wide DNA binding profile of SOX3 in both NPCs 
and postnatal testes, two very different sources of SOX3 expressing cells. We 
identified 8064 binding sites within NPCs derived from cultured mouse embryonic 
stem cells, linking SOX3 to a number of different neural development pathways. 
Additionally, we identified 778 SOX3 binding sites within postnatal day 7 mouse 
testes, linking SOX3 to the control of histones and histone variants, most of which 
was also true for NPCs.  
We utilised our Sox3 null mouse model and a number of different marker genes of 
spermatogenesis to identify that SOX3 is found within the committed progenitor 
fraction of the undifferentiated spermatogonial pool. We identified that SOX3 is 
required for the transition from a GFRα1+ state to a NGN3+ committed progenitor 
state, and in the absence of SOX3 GFRα1+ cells accumulate and spermatogonia fail 
to differentiate, leading to empty testes with no mature sperm. We provide further 
evidence that Ngn3 is a direct target of SOX3 in both NPCs and the testes albeit 
thought different regulatory regions.  
We have generated two invaluable genome wide ChIP-seq datasets that will 
deepen our understanding of mechanisms by which SOX3 controls context-specific 
differentiation. Taken together, the data presented in this thesis expand our 
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Complex organisms develop from single cells though an intricate process of cell 
division and differentiation requiring highly specific spatial and temporal gene 
expression. This tightly regulated gene expression is responsible for the 
development of individual organs, such as the brain, from the same starting genetic 
material. Gene expression is regulated by a number of different mechanisms such 
as transcription factors (TF) promoting or repressing expression and chromatin 
remodelling via epigenetic modifications (e.g. DNA and histone methylation). 
Additionally there are mechanisms for posttranscriptional regulation such as micro 
RNAs (miRNA), non-coding RNAs (ncRNAs), and RNA interference (RNAi), which 
regulate transcripts and translation following transcription. Transcriptional 
initiation begins at the promoter of genes. The factors required to initiate this 
process can be found not only at the promoter but also at enhancer elements, 
which are sometimes great distances away. It is also thought that TFs rarely act 
alone; rather, they act in tandem with other TFs and can act as adaptors to form 
protein complexes at specific sites within the genome. This thesis investigates the 
role of the TF SOX3 in two crucial developmental processes, neurogenesis and 
spermatogenesis.  
 
1.1.1 GENE TRANSCRIPTION AND TRANSCRIPTION FACTORS 
Transcription occurs when RNA polymerase recognises the promoter region of a 
gene and initiates DNA-dependant RNA synthesis. Three classes of RNA 
polymerase (Pol) exist [1]; RNA polymerase I (Pol I) - transcribes ribosomal RNAs, 
RNA polymerase II (Pol II)– transcribes messenger RNAs (mRNA) and ncRNAs, and 
RNA polymerase III (Pol III)– transcribes transfer RNAs [2]. Tight control of 
transcription is required to prevent every gene from being expressed all the time.  
As such, each type of cell will express a unique combination of genes providing cell 
identity and function.  Part of this control is provided by chromatin structure, where 
closed chromatin prevents Pols from binding DNA and initiating transcription [3]. 
Compacted “closed” chromatin, consisting of large numbers of nucleosomes 
(heterochromatin), is inaccessible by Pol. Remodelling the chromatin structure by 
modifying histones, the protein subunits of nucleosomes, can open up chromatin 
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making it accessible and allow transcription [4,5]. In addition to chromatin, TFs 
provide another layer of transcriptional regulation.  
Transcription factors are proteins that bind specific sequences of DNA, elicit 
changes in genomic regulation ultimately regulating gene expression by guiding 
Pols to promoters [6-9]. They are the second largest group of proteins in humans 
and mice [10]. In humans there are approximately 1600 known TFs belonging to 100 
different TF families [11]. 1198 have an orthologous TF in mouse [11,12]. TFs recruit 
other proteins through their transactivation domains [13] to regulate promoter 
accessibility and transcription initiation [14]. While a majority of these TFs bind only 
to open chromatin regions of DNA, some have the ability to bind closed DNA 
compacted around nucleosomes, otherwise known as pioneer factors [15], as 
discussed below.  
TFs control gene transcription through binding at proximal promoter regions, or at 
a distance via enhancers. Enhancers are often found large distances away from 
their target promoters (1Mbp or more away [16]). However through DNA looping 
and supercoiling, distant enhancers are brought closer to promoters in order to 
function. Enhancers are not required to remain in a single orientation, nor do they 
have to be found on the same chromosome as the promoter that they are affecting 
[17]. Enhancers often consist of binding sites for a number of different TFs allowing 
for cooperative gene control, or activation in different tissues with different TFs [18], 
(Figure 1.1). Combinations of promoters and enhancers, each consisting of different 
TF binding motifs, provide extra control and fine tuning of gene expression. This 
delivers cell type or tissue specific control and provides redundancy mechanisms 




Figure 1.1. Enhancers driving gene expression. Schematic representation of a 
distant enhancer driving the expression of a gene through DNA looping. Enhancers 
have been found up to 1Mb away from their target promoters. Enhancers are bound 
by TFs which aid in the recruitment of Pol II to gene promoters. Histones 
surrounding active enhancers have increased H3K27ac and H3K4me1 
modifications, while those at inactive enhancers tend to have high levels of 
H3K4me3. Enhancer 1 and enhancer 2 are shown to highlight expression of the 





1.1.2 PIONEER FACTORS: TRANSCRIPTION FACTORS WITH 
AN EXTRA TWIST 
Long after the original discovery of TFs and their ability to control gene expression, 
some TFs were found to have non-canonical functions beyond normal 
transcriptional regulation. Some TFs can also act as pioneer factors by directly 
binding compact/condensed chromatin, where most TFs are unable to bind 
condensed chromatin alone [15]. The chromatin landscape can be difficult for a TF 
to navigate, as highly compact regions of the genome prevent TFs from binding. 
This mechanism prevents inappropriate expression of target genes. Classical 
chromatin remodelling is controlled by histone modifiers (such as histone 
acetyltransferases, deacetlyases, kinases and methyl transferases) or ATP-
dependant remodellers (the SWI/SNF, ISWI, CHD and INO80 families) that 
physically move or remove nucleosomes from DNA [20,21]. These proteins create 
long lasting changes to chromatin structure, whereas TFs do not always require 
permanent access to enhancers. Pioneer factors deliver a transient method for 
providing access to enhancers [22].  
Pioneer factors can bind condensed chromatin, and through mechanisms that are 
still mostly unknown, remodel the chromatin into a more open state [22]. Pioneer 
factors such as the FoxA family, do this without requiring ATP or ATP-dependent 
re-modellers [23]. They have also been linked with altering histones and their post 
translational modifications [24]. It is currently thought that pioneer factors bind 
closed chromatin but cannot initiate transcription of their target genes directly 
while chromatin remains in a closed state. However, once the chromatin has 
opened up they can recruit other cooperative factors and together they can initiate 
transcription [24-26] (Figure 1.2).  While pioneer factors may be able to bind 
condensed chromatin to activate silent genes and enhancers, heterochromatin 
(tightly condensed and transcriptionally inert DNA) generally excludes pioneer 
factor binding. These regions are often shut down as a mechanism to retain cell 





Figure 1.2. Pioneer factors vs transcription factors. Pioneer factors can recognise 
their DNA binding motifs on the outside of nucleosomes. Partial motif recognition is 
sufficient for some pioneer factors. Regular TFs cannot bind their DNA binding 
motifs in closed chromatin. Both TFs and some pioneer factors can bind promoters 




The compact nature of closed chromatin is one of the reasons why most TFs 
cannot bind. There are two main mechanisms through which pioneer factors can 
bind closed DNA. Some pioneer factors (such as SOX2, Oct3/4 or KLF4) can target 
closed chromatin with only part of their DBD on the surface of a nucleosome [28]. 
Other pioneer factors (such as FOXA) are structurally capable of binding the whole 
motif when DNA is bound by a nucleosome through a “winged” DBD providing 
flexibility within the protein structure [29-31]. Once bound to condensed chromatin, 
these pioneer factors recruit coregulators and/or chromatin remodellers to open 
up the chromatin making it accessible. FOXA1 can recruit MLL3 to nucleosomes, 
leading to the addition of mono H3K4 methylation at enhancer elements [32]. Aside 
from a few specific examples, the molecular mechanisms behind the majority of 
this remodelling are largely unknown. Most of these pioneer factors can also 
function as ‘classical’ TFs with a more direct role in influencing gene expression, 
through binding at open chromatin [33]. 
The identification of pioneer factors and their activity has added additional layers 
of complexity to the already intricate mechanisms of transcriptional regulation. It 
is now known that closed chromatin (once thought to remain silent without 
permanent chromatin remodelling), can be transiently modified by pioneer factors 
allowing transcription from within an otherwise silent domain [24]. Additionally, 
pioneer factors provide cells with the opportunity to prime genes for expression 





1.1.3 CHARACTERISING TRANSCRIPTION FACTORS 
DNase footprinting and electrophoretic mobility shift assays (EMSA) [34] are two 
techniques used to map and characterise DNA binding motifs, as well as quantitate 
the strength of DNA binding. Additionally, these techniques can be used for the 
identification of novel TFs when coupled with other methods (N-terminal peptide 
sequencing or one-hybrid screens). N-terminal peptide sequencing is a chemical 
based process developed in the 1950s, where a single amino acid is removed from 
the N-terminus of a peptide and identified by chromatography, before repeating 
for subsequent amino acids. Proteins that bind DNA as identified by DNase/EMSA 
can then be identified by sequencing. Yeast one-hybrid screens, employ a library 
of proteins that are fused to a trans-activation domain, each yeast colony 
expresses one fusion protein. A reporter construct contains a DNA fragment of 
interest preceding a reporter gene, the reporter gene is activated only when the 
fusion protein binds to the DNA fragment. Upon activation of the reporter gene, the 
plasmid can be isolated and protein identified through sequencing of the plasmid 
encoding the fusion protein.  
These techniques facilitated identification of TFs belonging to the most common 
TF families, such as homeodomain, basic helix-loop-helix, nuclear hormone 
receptors and basic leucine zippers, back as long ago as the 1980s [35]. Since then, 
most TFs have been identified through sequence homology of their DBDs. It should 
be noted, that although novel TFs can be identified through DBD homology, some 
TFs identified this way fail to bind DNA, such as the CERS type homeodomain 
proteins [36].  
As mentioned above EMSA and DNase footprinting allow for the characterisation 
of DNA binding motifs. These systems can be used to introduce point mutations 
that can inhibit or strengthen DNA binding and be used to identify critical 
nucleotides. In general DNA binding motifs are only 8-12bp in length [37], as these 
sequences will often exist in many thousands of locations throughout the genome 
further characterisation is required to identify where a TF binds throughout the 
genome. Chromatin immunoprecipitation (ChIP) is a method that has been adapted 
to do exactly that. 
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ChIP was originally developed as a technique to identify cooperative interactions 
between histones and DNA [38,39]. It was initially used to map the locations of post 
translationally modified histones (including methylated, acetylated and 
phosphorylated) throughout the genome. A summary of the ChIP process is shown 
in Figure 1.3. Since its inception, the ChIP assay has been extended to a wide range 
of protein-DNA interactions [40], including TFs. Initially ChIP was limited by 
downstream analyses, PCR on a small number of regions, or through targeted 
microarrays providing probes for basic promoters and known enhancer regions 
only. In 2007 ChIP was coupled with high throughput next generation sequencing 
[41-43]. This provided the ability to sequence all DNA fragments that have been 
precipitated and bound by the protein of interest, providing an invaluable discovery 
technique for genome wide interrogation.  
ChIP-Seq is now a mainstream technique used in genomic and epigenomic profiling 
and has begun to reshape our understanding of many cellular processes [44] 
including transcriptional regulation, epigenetic organisation and chromatin 
modelling [45,46]. One such feature is the genome wide mapping of TF binding 
sites. Many ChIP-seq datasets exists on a wide range of TFs in a wide range of 
tissues and cell lines. Some of the initial ChIP-seq experiments demonstrated that 
the number of unique binding sites an individual TFs have can vary considerably 
[41-43,47]. Along with identifying where in the genome TFs bind ChIP-seq is also 
useful in identifying what DNA binding motifs TFs like to bind. Prior to ChIP-seq, the 
TF Neuron-Restrictive Silencer Factor (NRSF) was known to have a canonical 
binding motif that existed as two halves, ChIP-Seq helped demonstrate that the 
spacing between these two halves can be quite variable [48].  
ChIP-Seq has been an extremely valuable tool in exploring the binding profiles of 
TFs. We now know that TFs are significantly more promiscuous than originally 
thought, bound at hundreds to tens of thousands of unique locations within the 
genome. However this still leave us questioning what these TFs do at all these sites.   
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Figure 1.3. Summary of chromatin immunoprecipitation. DNA and proteins are 
reversibly cross-linked, DNA is sheared into small fragments usually around 200-
1000bp in length, followed by the precipitation of protein-DNA complexes using an 
antibody specific for the histone/modification of interest. Cross links are reversed 
using salt and heat, and the DNA is purified. Enriched DNA is then assessed by PCR. 
Figure adapted from Collas et al. 2010 [49]. 
LIBRARY NOTE:
This image has been removed
to comply with copyright.
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1.2.1 SOX TRANSCRIPTION FACTOR FAMILY 
One of the 100 different TF families is the Sex-determining region-Y (SRY) related 
high mobility group (HMG) box (SOX) family. The SOX family contains 
approximately 30 members in vertebrates, 20 of which are orthologous between 
the mouse and human genomes [50], and is the 5th largest family of transcription 
factors [11]. Each member exhibits regionally restricted expression during 
embryogenesis, some of which is maintained beyond embryonic development into 
the adult. Almost all tissues in the developing embryo express one or more of the 
SOX TFs [51,52] (Table 1.1).  
The SOX family have been grouped by identity within the HMG box. Each SOX 
member shares a minimum of 50% amino acid identity within this domain with the 
founding member SRY [51]. The HMG box is a DNA binding domain that binds to 
specific DNA sequences via the minor groove and, depending on the size and 
structure of the remainder of the protein, causes DNA to bend by 30-113 [53]. The 
HMG box of SOX proteins recognise variations of the core consensus sequence 
AACAAW (W = A or T) [54-57]. Additionally, SOX genes are grouped by amino acid 
identity outside the HMG domain, resulting in 8 groups, SOXA – SOXH. Each group 
shares between 70 and 95% amino acid identity outside the HMG box (Figure 1.4) 
[51,53].  
In addition to sharing high amino acid identity, SOX members within groups tend to 
share similar biological functions [56,58]. The SoxB1 group are all expressed within 
neural progenitor cells (NPC) and employ similar biological functions to each other 
[59,60]. The SoxF group are all expressed during vasculogenesis and share the role 
of controlling vasculature epithelial cell function [61-63]. The SOX family have 
originated through duplication events that are likely to have included significant 
regulatory elements controlling cell type specific expression, leading to similar 
groups being expressed in similar patterns.   
Due to the large number of tissues that express one or more of these TFs, it’s no 
surprise that mutations or altered expression of these factors have been implicated 
in a variety of diseases. SOX10 is expressed within neural crest cells. Heterozygous 
SOX10 mutations are associated with Hirschsprung disease, a congenital 
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aganglionic megacolon disorder [64,65] which is thought to be linked to neural 
crest cell dysfunction [64].  
Both SOX17 and SOX18 are normally expressed during vasculogenesis and 
mutations in either of these TF genes has been linked to reduced endothelial cell 
function and regeneration, predisposing individuals to vascular disorders [63]. 
SOX17 has been linked to intracranial aneurysms [66], while SOX18 has been linked 
to advanced coronary atherosclerotic lesions [61].  
SOX9 is expressed in chondrocytes, where it regulates differentiation. Mutations in 
and near SOX9 cause campomelic dysplasia (CD), a genetic disorder resulting in 
bowing of bones, skeletal and exoskeletal defects [67]. Additionally, 75% of XY 
males with CD exhibit male-to-female sex reversal [68]. CD is lethal in 95% of 
neonates, where death occurs as a result of respiratory insufficiency [69]. Due to 
varying severity of the disease, some individuals (5-10%) with CD survive into 
adulthood [70].  
While there are only a few SOX family TFs, they play important roles in both mouse 
and human development. Understanding how these TFs work will provide valuable 
information towards mammalian development.  
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Table 1.1. SOX family location, function and regions of expression. The table 
demonstrates the diverse expression of the SOX genes in a range of embryonic 
and adult tissues. (Collated from Pevny et al., 1997 and Lefebvre et al., 2007.) 
Group Gene Chromosome Expression Function 
Group A  Sry  Y Genital ridge, testis, brain 
[71] 
Male sex determination and brain sexual 
differentiation 
Group B1 Sox1 8 Embryonic CNS, lens  Forebrain development, chromatin 
architecture, neuron migration 
  Sox2 3 ICM, primitive ectoderm, 
CNS, PNS, embryonic gut, 
endoderm 
CNS development, neuron fate 
commitment, embryonic organ 
development 
  Sox3  X Embryonic CNS, gonads Specify stem cell identity, 
gonadogenesis, CNS development 
SoxB2 Sox14 9 Midbrain, Skeletal muscle Neurogenesis - counteracts Sox1-3 
activity to promote neuron 
differentiation 
  Sox21 14 embryonic CNS Neurogenesis - counteracts Sox1-3 
activity to promote neuron 
differentiation 
Group C  Sox4 13 Embryonic heart and spinal 
cord, adult pre-B and pre-T 
cells  
- 
 Sox11 12 Embryonic CNS, post-
mitotic neurons 
Organ development - lung, stomach, 
pancreas, spleen, eye and skeleton 
  Sox12 2 Fetal Testis - 
Group D  Sox5 6 Adult testis  Skeletogenesis, neural crest 
development, gliogenesis 
  Sox6 7 Embryonic CNS, adult testis Cardiac conduction, skeletogenesis, 
gliogenesis, erythropoiesis 
  Sox13 1 Kidney, Ovary, Pancreas Lymphopoiesis 
Group E  Sox8 17 Gliogenesis, Testis 
development, osteogenesis, 
neural crest 
Cell fate commitment and maturation, 
CNS development, formation of neural 
crest and upkeep 
  Sox9 11 Chondrocyte, genital ridge 
and adult testis, CNS, 
notochord  
Male gonad development, cartilage 
condensation, apoptosis regulation 
  Sox10 15 PNS, CNS Neural crest, inner ear formation 
Group F  Sox7 14 CNS, heart Cardio genesis 
  Sox17 1 Endoderm, testis, uterus[72] Endoderm formation, angiogenesis, 
epithelial-stromal cross talk 
  Sox18  2 Heart, lung, spleen, skeletal 
muscle, liver and brain of 
adult  
Angiogenesis, vasculogenesis 
Group G Sox15 11 Pancreas Skeletal Muscle regeneration 
Group H Sox30 11 Heart, brain, lung, testis, 
mesonephros 
- 




Figure 1.4. The SOX family of transcription factors. Schematic representation of 
the SOX family and its 8 subgroups. All SOX proteins shown here are based on the 
mouse variant, except for SoxB2 (Chicken). Group H is not shown. Various structural 
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features are shown including the HMG box (black box) and known activation and 
repression domains. Modified from Bowles et al. 2000 [56]. 
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1.2.2 SOX3 ACTIVATES AND REPRESSES TRANSCRIPTION 
Sox3 is a single exon gene located on the X chromosome and belongs to the SoxB1 
subgroup (SOX1/2/3) of the SOX transcription factor family. It is thought that Sox3 
is the gene from which Sry, the male-determining gene and first described member 
of the SOX family, has evolved [73].  
SOX3 has been implicated as a transcriptional activator by means of reporter 
assays, in which increasing the dosage of SOX3 leads to increased expression of a 
luciferase reporter construct containing either the SOCM or Hesx1 proximal 
promoter (known to contain SOX biding regions) [59,74]. Transactivation activity 
has also been shown in vitro using Sox3-Gal4 fusion proteins and a luciferase 
reporter construct containing Gal4 binding sites [74].  
Bylund et al. 2003 used chick embryos to investigate the transcriptional activity of 
SOXB1 proteins. Over expression of WT cSOX1/2/3 results in an inhibition of neural 
differentiation in the chick neural tube. To identify whether this activity was due to 
gene activation or repression, HMG domains of cSOX1, cSOX2 or cSOX3 were fused 
to either the activator domain from the herpes simplex virus VP16 protein, a potent 
transcriptional activator, or the repressor domain of the Drosophila Engrailed 
represser EnR [59]. Only the VP16 (activator) constructs were able to suppress the 
generation of differentiated neurons when expressed in the chick neural tube, and 
therefore replicating WT function [59]. 
In contrast, Zebrafish SOX3 has also been shown to have transcriptional repressor 
activities. In Zebrafish the SOX3 HMG:EnR fusion protein mimics the repression of 
genes such as boz, sqt and gsc observed with WT Sox3; while the SOX3 HMG:VP16 
fusion protein does not [75]. The above-mentioned studies suggest that SOX3 has 
both transactivation and transcriptional repressive abilities, dependant on the 
cellular context.  
The duality of SOX3’s transcriptional abilities (acting as both and activator and 
repressor) is a common feature of TFs, increasing the complexity transcriptional 
regulation. Transcriptional regulation can be influenced by the affinity of a TF for 
a binding site [76], the number of binding sites [77,78], and by temporally controlled 
co-occupancy with partner factors [79-81]. It has been proposed that cooperative 
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binding of TFs and their binding partners can act as a buffer to variations in protein 
levels, providing a protection mechanism for important biological functions [82]. 
In addition to regular TF activities, SOX3 has been shown to have pioneer factor 
capabilities. SOX3 binds to a large number of genes that are not active in NPCs, but 
later bound and activated by SOXC TFs [55]. Histone profiling of the genes pre-
bound by SOX3 were also consistent with promoter and enhancers in a poised state 
and ready to be transcribed [55]. While current experimental evidence points to 
SOX3 having pioneer factor activity, this has not yet been demonstrated directly. 
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1.2.3 EXPRESSION OF SOX3 IN EMBRYONIC AND ADULT 
NEURAL TISSUES 
Successful development of mouse brain is a highly complex process requiring 
precise expression of thousands of genes.  Transcription factors are just one of 
numerous control mechanisms that define correct cell fate, function and spatial 
migration. Neural cell identity emerges from the ectoderm, and brain development 
continues throughout embryogenesis through to early postnatal life [83]. During 
embryogenesis there are large numbers of NPCs, undifferentiated cells that give 
rise to all radial glial and neuronal cells. Some NPCs can also be found in the adult 
brain, particularly in the sub-ventricular and –granular zones, providing a source of 
cells for neurogenesis in the adult brain [84-88]. In addition to these NPCs, the 
mouse brain comprises many different terminally differentiated cell types, 
including astrocytes, oligodendrocytes and neurons, that all develop at different 
times throughout embryogenesis and early postnatal life.  
In mice, Sox3 expression has been detected from embryonic day (E) 7.5 in the 
neural plate [74,89,90] from which the entire central nervous system (CNS) is 
derived (Figure 1.5A). At E10.5 Sox3 is highly expressed within the developing brain, 
specifically within the telencephalon, that forms the cerebral cortex, within the 
diencephalon that forms the presumptive hypothalamus, thalamus and optic nerve 
(Figure 1.5B) [91]. At E11.5 Sox3 is expressed within the infundibular recess, which 
together with Rathke’s pouch, develops into the pituitary [92] (Figure 1.5C). By E13.5 
Sox3 expression is restricted to the sub-ventricular cell layer and is generally down 
regulated in differentiated neurons [93]. At E14.5, Sox3 is still expressed within the 
sub-ventricular progenitor cell layer lining the lateral ventricles (Figure 1.5D). 
Together these data demonstrate Sox3 expression is restricted to NPCs. 
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Figure 1.5. Expression of Sox3 throughout embryogenesis. In situ hybridisation of 
Sox3 in the developing embryo from 7.5dpc to 14.5dpc. (A) Expression at 7.5dpc 
indicating Sox3 is found within the neural plate. (B) Whole mount in situ shows Sox3 
is expressed right throughout the developing CNS, including the forebrain (FB), 
midbrain (MB), hindbrain (HB), and spinal cord (SC). (C) Sagittal section of an 11.5 
mouse embryo showing Sox3 expression in the infundibulum (INF), and the 
presumptive hypothalamus (HYPO), expression is not detected in Rathke’s pouch 
(RP). (D) Transverse section of a 14.5dpc mouse embryo, Sox3 is restricted to the 
sub-ventricular layer of the lateral ventricles (Thomas, P. Unpublished). Figure 
adapted from Solomon et al. 2007 and Brunelli et al. 2003 [90,91]. 
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In addition to the well-characterised embryonic expression of Sox3, two recent 
publications have characterised the expression of SOX3 in the adult mouse brain. 
SOX3 expression can be detected in the neurogenic zones of the hippocampus and 
the sub-ventricular zone of the lateral ventricles within the adult brain [93]. 
Furthermore, SOX3 protein is detected in the adult cerebellum (as well as the 
developing embryonic cerebellum), and is restricted within the cerebellar glial cell 
system [94].  
These data provide a comprehensive expression profile, at both the RNA and 
protein level, pertaining to the timing and location of SOX3’s expression. Sox3 is 
found in numerous regions of the developing brain, indicating that is likely to play 
an important role in the successful formation of the brain. The function of SOX3 has 
been assessed through a number of in vitro and in vivo model systems, discussed 
below.  
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1.2.4 THE FUNCTION OF SOX3 IN NEUROGENESIS 
A number of functional studies have been performed in different tissues and model 
organisms (including mice, chicken, and xenopus) in order to identify the function 
of SOX3. cSOX3, along with the other SOXB1 genes cSOX1 and cSOX2, was shown to 
regulate neurogenesis in the chick neural tube by maintaining NPCs in an 
undifferentiated state [59]. Overexpression of any of the cSoxB1 genes in the neural 
tube inhibited neurogenesis, as seen by the absence of neuron markers, p27, NeuN 
and Tuj1. Conversely, the repression of SoxB1 genes prompted premature neuronal 
cells differentiation [59]. Whilst it has been demonstrated that SOX3 has both 
activating and repressive capabilities (discussed above), only the activating 
function appear to be required in the chicken neural tube.  
Another study demonstrated a functional relationship between Notch and SoxB1 
genes. Neuronal differentiation was blocked through the overexpression of either 
Notch or SOX3 within the chick spinal cord, however Notch’s ability to inhibit 
differentiation is dependent on the simultaneous expression of functional SOX3 
[95]. These data help solidify cSOX3’s role in the maintenance of neural progenitors 
and suggest that cSOX3/B1 can act alone, or in conjunction with Notch.  
In mice, Sox2 and Sox3 (but not Sox1) are expressed in oligodendroglial cells, where 
they act as differentiation factors [96]. In mouse embryos lacking either Sox2 
orSox3 individually or the combined loss of both Sox2 and Sox3, there is a reduction 
in the number of cells expressing myelin genes indicating a lack of terminal 
differentiation in oligodendrocytes [96]. It is also proposed that SOX2/3 act as 
pioneer factors in oligodenroglial progenitor cells (OPCs), where they pre-bind 
genes in progenitor cells that are activated later by other SOX families. 
These studies have highlighted two different functions of SOX3, one maintaining 
cells in a progenitor state, and the second acting as a pro-differentiation factor. 
There are a few potential mechanisms that might explain how one TF can have 
multiple functions. SOX3 may be acting as a pioneer factor in one cell type and not 
the other, altering the cellular outcome. Alternatively, the simplest explanation is 
that different cell types will express different cofactors and it is these different 
combination of cofactors which helps determine which role SOX3 plays.   
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1.2.5 BINDING PARTNERS AND COFACTORS OF SOX 
PROTEINS 
As mentioned above, many TFs do not act alone, and often require specific partner 
factors to perform their desired function. TF (and many proteins in general) can 
form dimers, either homo- or hetero-typic. Some require dimerisation to occur 
before they can bind DNA, while others require the presence of DNA and their DNA 
binding motifs in order to dimerise [97]. Partner proteins can strengthen DNA 
binding specificity by increasing the number of nucleotides recognised by the TF 
complex. Changes in partner protein concentrations can influence TF activity 
independent of the primary TF abundance [98]. They also act to reduce off target 
binding and transcriptional noise, resulting in more resourceful transcription 
[99,100]. 
The SOX TFs all recognise and bind similar DNA motifs. Given this similarity in 
binding motif preferences, it has been proposed that SOX genes acquire target 
specificity through cofactors [53,101]. Studies interrogating the binding partners of 
SOX2, SOX10 and SOX18 have shown that the HMG domain of SOX proteins can 
function as both a DNA binding domain and a protein binding interface [62,102-
104]. SOX2 and PAX6 have been shown to regulate the DC5 enhancer element of 
the δ-crystallin gene cooperatively [105]. ChIP analyses have demonstrated that 
these TFs can only bind the regulatory element when both factors are present and 
thus cofactors are required for their function [105].   
In vitro reporter assays have been used to demonstrate SOX2 binds cooperatively 
with POU family TFs to activate the Nes30 enhancer, an enhancer found in intron 2 
of Nestin [106]. TFs shown to interact cooperatively with SOX2 include POU class II, 
III and IV members including BRN1, BRN2, BRN3, OCT2, OCT3 and OCT6. 
Additionally, SOX1 and SOX3 were also shown to cooperatively interact with BRN2 
drive expression from the Nes30 enhancer [106].  
This information provides insight into the mechanism by which SOX proteins obtain 
target specificity. Currently the only information regarding SOX3’s cofactors exits 
from in vitro assays, there is no information identifying or confirming in vivo 
cofactors of SOX3.   
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1.2.6 FUNCTION OF SOX3 IN MICE 
As discussed above, we know Sox3 is found within the NPCs of the developing 
mouse brain and two adult neurogenic zones in the adult mouse brain. A robust 
method for the identification of cell function is through deleting the gene in mice. 
To date, the function of SOX3 has been investigated through two independent Sox3 
null (or Knock Out) mouse models.  
One KO mouse line was generated using homologous recombination, where the 
Sox3 open reading frame (ORF) was replaced with the green fluorescent protein 
(GFP) ORF [92]. These Sox3 null mice exhibit hypothalamic hypoplasia as well as 
variable dwarfism [92]. Sox3 null mouse embryos (from E11.5 through E14.5) show 
a bifurcation and expansion of the dorsal side of Rathke’s pouch (Figure 1.6A & 1.6B) 
[92], while 3 week old mice have some severe CNS malformations including 
dysgenesis of the corpus callosum and failure of the dorsal hippocampus to cross 
the midline (Figure 1.6C & 1.6D). Taken together this indicates the importance of 
Sox3 expression in the mouse CNS for both embryonic and postnatal brain 
development. Although Sox3 expression is detected in the embryonic and adult 
cerebellum, Sox3 null mice do no exhibit any cerebellar phenotypes [94]. In addition 
to these neural defects, Sox3 null mice also exhibit a block in spermatogenesis 
(discussed in further detail below).  
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Figure 1.6. CNS defects in Sox3 null mice. (A, B) Sagittal sections 11.5dpc brains 
from WT (A) and Sox3-null embryos (B). Rathke's pouch is dorsally expanded and 
bifurcated and the evagination of the infundibulum was less pronounced (arrow) 
in the Sox3 null embryos. Transverse section 3-week-old brains from WT (A) 
and Sox3-null mice (B). Dysgenesis of the corpus callosum is seen in the Sox3 null 
brains (arrow). Hyp, presumptive hypothalamus; RP, Rathke’s pouch; Inf, 
infundibulum; ICF, intercerebral fissure; Cca, corpus callosum; Dhc dorsal 
hippocampal commissure. Adapted from Rizzoti et al. 2004 [92]. 
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A second study has also generated an independent Sox3 null mouse line to study 
the effect of the loss of Sox3. LoxP sites were introduced to flank Sox3 by 
homologous recombination, followed by the excision of Sox3 by breeding the 
chimeras onto a Cre recombinase expressing line; no reporter gene was introduced 
[107]. These mice exhibited overgrown and misaligned teeth, variable dwarfism, 
and infertility [107]. No change in growth hormone levels was observed in these 
Sox3 null mice. Additionally it was reported that brain development was grossly 
normal, however this data is not presented [107,108]. Male Sox3 null mice showed 
postnatal hypogonadism and were identified as being sterile [108]. Further analysis 
into the effect of the loss of Sox3 on gonad function identified a role of Sox3 in the 
progression of spermatogenesis [108] (the role of Sox3 in spermatogenesis will be 
expanded on below). A germ cell specific Sox3 null mouse line confirmed the 
reduction in spermatogenesis was caused directly by the loss of Sox3 in the testis 
and was not secondary to a pituitary hormone deficiency [109]. Unlike the above-
mentioned study, no pituitary defects were identified in this line of Sox3 null mice 
[108].  
The difference in phenotype observed by the two different groups is most likely 
caused by the differences in genetic background [110]. It has been proposed that a 
mixed genetic background provides the quickest way to identify most strain 
dependent phenotypes [110]. This phenomenon is quite evident when comparing 
the two different Sox3 null mouse models. The Sox3 null model generated by Rizzoti 
et al. was produced and maintained on a mixed genetic background; 129/SvEv, 
C57BL/6J, and MF1 mouse strains. The Sox3 null line produced by Weiss et al. was 
produced on a 129/SvJ (and an unreported background from the transgenic CMV-
Cre mouse) background followed by backcrossing the null allele onto the C57BL/6J 
strain [107]. Neural phenotypes observed within the mixed background Sox3 null 
mice, were not present on the 129/SvJ or C57BL/6J backgrounds. Although 
different phenotypes are observed between the two Sox3 KO lines, the observed 
phenotypes are always within Sox3 expressing areas.  
Ultimately the CNS defects observed in Sox3 null mice appear to be quite minor, 
given its extensive expression in the developing CNS. This suggests that functional 
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redundancy, a functional backup mechanism through which the loss of a single 
gene is mitigated by another closely related gene, is occurring in Sox3 KO mice. 
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1.2.7 OVERLAPPING EXPRESSION AND FUNCTIONAL 
REDUNDANCY OF SOXB1 PROTEINS 
For functional redundancy to occur the expression of the redundant factors needs 
to either overlap, or be upregulated in response to the loss of the gene of interest.  
In the case of the SoxB1 subgroup, they are expressed in largely overlapping 
regions during early development. Sox2 is the first member of the SoxB1 family to 
be expressed during development and is detectable in the blastocyst inner cell 
mass and primitive embryonic endoderm, the pluripotent cell population within the 
embryo [111,112]. Like Sox3, by E7.5 Sox2 is expressed within the anterior 
neuroectoderm, but not within the posterior ectoderm [112]. By E9.5 Sox2 is 
expressed in the brain and neural tube as well as in some regions of the branchial 
arches and gut endoderm [113]. As cells begin to differentiate Sox2 is down 
regulated and becomes restricted to the ventricular zone [112]. 
Sox1 is initially expressed at E8 within the neural plate [60]. By E9.5 Sox1 is detected 
throughout the entire length of neural tube [114]. At E12.5 Sox1 is expressed in the 
ventricular and sub ventricular zones as well as the lens [114]. 
As outlined above, the expression pattern of Sox1 and Sox2 show extensive overlap 
during early development, particularly between E7.5-E10.5. This is also the case for 
the expression of Sox3. Although we see very similar patterns of expression 
between the three SoxB1 group members, this overlap is not complete as there are 
distinct regions of expression of only 1 or 2 of the genes (Figure 1.7). For example, 
Sox1 is expressed uniquely in the lens from E12.5 [115]. 
The SoxB1 proteins have been shown to share functional similarities including the 
observation that over expression of cSOX1, cSOX2 or cSOX3 in chick neural tube 
leads to the same effect of maintaining cells in a progenitor state (described 
above) [59].  The SoxB1 proteins have also been shown to bind the same DNA 
sequence, the SOX consensus motif (SOCM), through gel shift assays [89]. SOX1 
and SOX3 where shown to bind the SOCM containing probe with the same affinity 
while SOX2 was shown to bind with a greater affinity [89].  
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Figure 1.7. Overlapping SoxB1 expression during embryogenesis. Whole mount in 
situ hybridisation of mouse embryos ranging from 8-9.5dpc (1-14 somites). Embryos 
from 1-6 somites have been flattened. Extensive overlap of SoxB1 expression can 
be observed at all stages, with some small unique regions of expression for each 
TF. Key: Arrow heads, primitive streak; small arrows, ectoderm; large arrow, 
foregut, r, rhombomere; d, dorsal; v, ventral; h, heart; fg, foregut; se, surface 
ectoderm; ov, optic vesicle; np, nasal placode; op, otic placode. Figure adapted from 
Wood and Episkopou, 1999 [60]. 
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Due to the extensive overlap in expression and functional similarities between the 
SoxB1 proteins it is believed that functional redundancy is likely to occur between 
these proteins [89,92,115,116]. Sox3 is expressed widely throughout the developing 
CNS, however defects caused by the loss of SOX3 (as described above) might be 
ameliorated, due to the potential compensatory roles of SOX1 and SOX2. Similarly, 
CNS defects caused in relation to the loss of either SOX1 or the conditional loss of 
SOX2 in the CNS is also relatively mild, supporting this model [92,117]. The ablation 
of Sox2 in mice leads to early embryonic lethality [113], however the reduction of 
Sox2 expression through the deletion of a neuronal enhancer found within the Sox2 
locus leads to grossly normal development [117]. The embryonic lethality caused 
by the loss of Sox2 occurs during the stages of development where no other SoxB1 
members are expressed, which further supports the model of functional 
redundancy. 
Embryonic stem cells (ESC) are by definition pluripotent, a unique feature that 
allows them to become any cell in the organism. Sox2 is one of the genes required 
to maintain this pluripotency, as loss of Sox2 expression in ESCs results in the loss 
of pluripotency [118]. Expressing either Sox1 or Sox3 in ESCs that lack Sox2 results 
in the rescue of ESC pluripotency [119]. Interestingly, this functional redundancy was 
also observed with Drosophila SoxN, both in ESCs and in chimeric mice [119]. These 
experiments help strengthen the argument for SoxB1 functional redundancy, 
providing more in vitro and in vivo evidence. However cells alone and chimeric mice 
still leave many questions unanswered, without experimental evidence it is 
uncertain whether functional redundancy occurs in all tissues with overlapping 
SoxB1 expression. The chimeric mice generated by Niwa et al. 2016 do not 
completely answer the question of functional redundancy, there are WT cells 
present in these chimeras that may mask the true extent of SoxN’s ability to replace 
SOX2. Breeding these chimeras to create a SoxN knock-in mouse model would help 
strengthen this argument.   
Recently an ORF swap experiment was performed to answer these questions. Sox3 
ORF was replaced with Sox2 ORF in mice, utilizing CRISPR/Cas9 [120]. These mice 
expressed SOX2 in place of SOX3 and concluded that the expression of SOX2 in 
place of SOX3 can almost completely rescue the Sox3 null phenotype observed in 
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both the pituitary and testis [120]. Expression of genes in the spermatogenesis 
pathway were restored enough to rescue the phenotype, however not all genes 
returned to WT levels (eg. Ngn3 expression was still lower than WT). One possible 
explanation is that SOX2 may not have been present at endogenous SOX3 levels in 
WT mice. This decreased protein amount may explain the reduction in gene 
expression rescue, and as described earlier mice can be sensitive to incorrect SoxB1 
dosage. Alternatively, SOX2 may not be able to regulate SOX3 specific targets as 
well as it can regulate SOX2/SOXB1 targets. As regions of Sox3 specific expression 
have evolved, it is possible that SOX3 has developed unique ways to regulate Sox3 
specific target gene that SOX2 cannot match.  
These gene swap experiments help provide further in vitro and in vivo evidence 
towards the redundant roles of the SoxB1 family and highlight the importance of 
maintaining tight control over expression of the SoxB1 genes.   
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1.2.8 SOX3 AND HUMAN DISORDERS 
X-linked hypopituitarism (XH) is a male specific disorder characterised by growth
hormone (GH) deficiency as well as variable deficiencies in other pituitary
hormones [121]. Individuals with this disorder are short in stature due to GH
deficiency (dwarfism results if not treated with GH replacement therapy), and have
variable degrees of intellectual disability (ID) [90]. XH patients also have structural
abnormalities of the hypothalamic region as well as an ectopic posterior pituitary
[74,122]. To date there have been a number of individual families with unique
duplication events of varying size that include the SOX3 locus [122]. The most recent
investigation into XH has identified the smallest duplication event, 323.8kb in length.
Critically, the only brain gene included in these duplication events is SOX3
[74,121,122].
Duplication events including the SOX3 locus have also been linked to XX female-to-
male sex reversal. There are currently 5 reported individuals exhibiting sex reversal 
and varying degrees of pituitary hormone deficiencies [123-127]. Female-to-male 
sex reversal was also observed in transgenic mice with extra copies of Sox3 leading 
to ectopic expression in the developing bi-potential gonads [125]. SOX3 was 
proposed to act through mechanisms similar to that of SRY, resulting in the initiation 
of the male gonad pathway in the absence of a Y chromosome [125].   
As well as duplication events, mutations that cause the expansion of SOX3 
polyalanine tracts have also been shown to cause XH [74,128,129]. Polyalanine 
tracts have been associated with diseases in numerous different proteins [130]. In 
vitro experiments have shown the expansions cause the formation of cytoplasmic 
protein aggregates, as well as reducing transactivation capabilities [74,131]. 
However the expression of SOX3 polyalanine expansion mutants in vivo point 
towards it acting as a partial loss of function allele due to misfolding and clearance 
by the proteasome [130]. 
In contrast to the genomic duplications and polyalanine expansions of SOX3 that 
lead to XH, there have been several independent deletion events that lead to 
varying levels of ID. Three independent patients with deletions encompassing SOX3 
have presented with varied levels of ID and haemophilia B, one with a 6Mb deletion 
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[132,133], a second patient with a 2Mb deletion [134] and a third with a 2.3Mb 
deletion [135]. In addition there was a patient reported with a 2.1Mb deletion 
encompassing SOX3 and presenting with ID and mild facial abnormities [136]. 
Together these data highlight the importance for tightly controlled expression of 
SOX3, where both over and under dosage of SOX3 can lead to CNS defects. 
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1.3.1 SPERMATOGENESIS IN MICE 
Spermatogenesis is the process of sperm formation in the male testis, and is a 
complex process requiring precise timing and control of mitosis, meiosis and cell 
differentiation. It is through this complex process that SSCs, which comprise only 
0.03% of total germ cells in mice [137], amplify, differentiate and reduce to a haploid 
genome, resulting in millions of mature sperm each day.  
During embryogenesis, primordial germ cells migrate to the genital ridge, followed 
by differentiation into gonocytes [138]. In mice, this gonocyte population 
differentiates into spermatogonial stem cells by postnatal day 6 [138]. This process 
is rapid in mice when compared to humans due to the difference in pre-pubertal 
length, an average of 42 days in mice and 11.5 years in humans [139].  
During the first 6 postnatal days, gonocytes differentiate into a heterogeneous 
population of undifferentiated spermatogonia. This pool of undifferentiated 
spermatogonia consists of type A-single (As) spermatogonia or cysts of 2 or more 
spermatogonia termed A-paired (Apr) or A-aligned (Aal) respectively, and are 
located on the basal membrane of the seminiferous tubule [140-143]. As 
spermatogonia undergo either symmetrical cell division to form two identical As 
cells, maintaining the spermatogonia pool, or undergo incomplete cytokinesis 
during cell division to form Apr spermatogonia [142,144]. Apr continue this incomplete 
cell division process forming chains of Aal spermatogonia which can be 4, 8, 16 or 
sometimes 32 cells in length. Longer chains of Aal spermatogonia are believed to 
be committed to differentiation into A1 spermatogonia. Type A1 spermatogonia 
differentiate through a series of different differentiating spermatogonia including 
A2, A3, A4, intermediate (I), and Type B [143]. These cells differentiate in a 
synchronised manner and are located within the seminiferous tubules. Type B 
spermatogonia undergo meiosis to form secondary spermatocytes, followed by a 
second round of meiosis giving rise to haploid spermatids [143]. These spermatids 
finally undergo spermiogenesis, which involves a number of significant 
morphological changes to become spermatozoa, before they are ready to be 
released as mature sperm [145] (Figure 1.8). 
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Figure 1.8. Overview of mouse spermatogenesis [146]. 
An overview of spermatogenesis in mice, from undifferentiated stem 
spermatogonia through to mature sperm, including genes that have been shown 
to mark the different cell stages. Modified from Fayomi et al., 2018 [146]. 
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Type A and B spermatogonia were originally identified and distinguished by the 
amount of heterochromatin present in the nuclei of each type, type A have little to 
no heterochromatin, while type B nuclei consist of large quantities of 
heterochromatin. Heterochromatin is heavily condensed chromatin that is found in 
silenced genomic regions, nuclei with large amounts of heterochromatin are usually 
more differentiated, while those without are usually more undifferentiated. The 
entire spermatogenesis pathway revolves around intricate and rapid changes to 
chromatin state [147]. These changes in chromatin state are required to maintain 
chromosomal integrity throughout the large number of mitotic, meiotic and 
differentiation steps that occur. Errors during this process can lead to apoptosis, 
cell cycle arrest, and ultimately infertility [148]. 
Currently there are two different models regarding amplification of the 
spermatogonial stem cell population, the “As model” and the “fragmentation 
model”. The As model relies upon As spermatogonia undergoing either symmetrical 
cell division generating two identical As daughter cells, or undergoing incomplete 
cell division generating Apr spermatogonia. The outcome of cell division is 
dependent on the location and migration of the dividing As cell within the 
seminiferous tubule and their mitotic activity. Overall As cells have the same chance 
of self-renewal or differentiation [143]. This model implies that As cells are a 
homogenous population which contradicts studies that indicate As cells are a 
heterogeneous population [149-151].  
The “fragmentation model” has been proposed following long term lineage tracing 
of GFRα1-GFP and NGN3-GFP expressing spermatogonia and accounts for a 
heterogeneous As population [152]. Live cell imaging identified that a majority of As 
cell divisions were incomplete giving rise to Apr cells, and that Aal-4 cells fragment to 
repopulate the As population [153]. This model proposes that all undifferentiated 
spermatogonia, not just As cells, have the potential to belong to the stem cell pool 
[152].  
Undifferentiated spermatogonia are characterised by the expression of PLZF and 
E-CAD and do not express c-KIT while, conversely, differentiating spermatogonia
are characterised by the expression of c-KIT and not PLZF and E-CAD [154-157]. 
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GFRα1 and NGN3 are not only found heterogeneously within the undifferentiated 
spermatogonia pool, but they are also reciprocally expressed. GFRα1+ cells are 
usually As and Apr (with a small number of Aal being GFRα+), while NGN3+ cells are 
usually Aal spermatogonia (with a small number of As and Apr being NGN3+) 
[152,158-160]. Most NGN3+ spermatogonia will differentiate into c-Kit+ 
spermatogonia and subsequently continue through the differentiation pathway to 
become spermatozoa [159-161]. These two sub-populations of undifferentiated 
spermatogonia, either GFRα1+ or NGN3+, also exhibit different differentiation 
capabilities in response to retinoic acid stimulation due to the expression of RAR 
in NGN3+ cells [162]. The exposure of NGN3+/RAR+ cells to retinoic acid promotes 
differentiation. Seminiferous tubules have an abundant amount of retinoic acid 






1.3.2 EXPRESSION AND FUNCTION OF SOX3 IN MOUSE 
TESTES 
As mentioned earlier, Sox3 is expressed within the adult testis in mice, specifically 
within undifferentiated spermatogonia [108]. Sox3 deletion in mice leads to a block 
in spermatogenesis, however the mechanism behind this block remains unclear 
[92,107,108]. The severity of the spermatogenic block is dependent on the genetic 
background of the mouse strain, whereby C57Bl/6J mice exhibit the strongest 
phenotype. Mice from the Sox3/Sox2 ORF swap model by Adikusuma et al. 2017, 
demonstrate that the expression of Sox2 in place of Sox3 is sufficient to overcome 
the morphological and phenotypic alteration in the Sox3 null model. However, it 
should be noted that expression levels of key players in the spermatogenesis 
pathway, in particular Ngn3, did not return to normal wild type levels. This blockage 
highlights the importance of Sox3 expression during spermatogenesis, gaining a 
clearer understanding of the function of Sox3 in these cells is a critical step towards 
deciphering the delicate gene expression code that controls mouse 
spermatogenesis.  
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1.4 PROJECT RATIONALE AND AIMS 
As described above, Sox3 is a dosage sensitive regulator of CNS development, 
where altered expression of Sox3 leads to CNS defects observed in both humans 
and mice. Additionally, SOX3 plays a key role in spermatogenesis, as demonstrated 
by the spermatogenic block observed in Sox3 null mice. To date there have been a 
number of studies looking at how SOX3 functions, both endogenously and 
ectopically within cells and cell lines, as well as within two independently generated 
Sox3 null mouse models. While these functions are of key interest, the mechanisms 
surrounding SOX3’s transcriptional activity still remain unclear, in particular the 
transcriptional targets of SOX3. We set out to develop two highly comparable SOX3 
ChIP-seq datasets from two different SOX3 expressing cell types using the same 
antibody. Surprisingly, the mechanism/s through which SOX3 controls the 
progression of spermatogenesis remains largely unknown. These aspects were 
therefore the focus of the research in this thesis, with the specific aims of;  
 
1. Characterising the global binding profile SOX3 and its impact on transcription in 
mouse neural progenitor cells  
2. Interrogate the role of SOX3 in spermatogenesis by: 
a) Using the Sox3 null mouse model to identify the mechanisms through which 
SOX3 controls spermatogenesis and clarify which cell type/s express SOX3  
b) Characterising the global binding profile of SOX3 and its impact on 
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2.1 CHARACTERISING THE GLOBAL TRANSCRIPTIONAL 
MECHANISMS OF SOX3 IN NEURAL PROGENITOR CELLS 
SOX3 is a transcription factor expressed within most NPCs of the developing CNS, 
and is required for normal brain development in both mice and humans. The 
molecular mechanisms underlining the function of SOX3 in NPCs is addressed in 
Publication I, entitled “Identification of highly conserved putative developmental 
enhancers bound by SOX3 in neural progenitors using ChIP-Seq”. 
For the study in Publication I, we utilized the highly specific SOX3 antibody, validated 
in our lab [93], to generate a ChIP-Seq data set from ESC derived NPCs. Publication 
I identified 8064 binding sites within the mouse genome, a majority of which are 
located at either intronic or intergenic locations. We demonstrated that SOX3 binds 
extensively to evolutionarily conserved sequences located in or near 
neurodevelopmental genes. We identified numerous potential large-scale 
interactions where SOX3 links the promoters and enhancers of distant genes on a 
genome wide scale. Additionally, we cross examined our dataset with a SOX2 and 
an additional SOX3 ChIP-seq dataset from NPCs to explore potential mechanisms 




2.2 EXPLORING THE MOLECULAR MECHANISMS OF SOX3 IN 
MOUSE TESTIS  
The main research focus surrounding the function of SOX3 relates to its expression 
within NPC populations, both in vivo and in vitro. Sox3 expression can also be found 
within other tissues such as the heart or testis. Previous publications have shown 
that Sox3 is expressed within the spermatogonial progenitor cells located within the 
testis. Loss of Sox3 from spermatogonial progenitor cells leads to a variable 
spermatogenic block dependent of the genetic background of the mice, leading to 
sub fertile or infertile mice. Currently the SOX3’s role in spermatogonia and the 
mechanisms behind this spermatogenic block are poorly understood. We set out 
to explore this phenotype with two different approaches. The first being a closer 
look at SOX3 in the mouse testes, investigating which sub-types of Type A 
spermatogonia express SOX3, and examining the SOX3 null mice model to identify 
when and why the block occurs. Our second approach was using ChIP-seq to map 
where SOX3 is found in the genome of mouse testes.    
 
2.2.1 THE ROLE OF SOX3 IN TYPE A SPERMATOGONIA 
In Manuscript I, “SOX3 promotes generation of committed spermatogonia in 
postnatal mouse testes”, we investigate the molecular mechanisms surrounding the 
spermatogenic block as caused by a loss of Sox3 expression in 6th generation 
backcrossed 129Sv mice. It was found that SOX3 expression was restricted to the 
late committed subset of type A spermatogonia. SOX3 was found to be highly co-
expressed with PLZF, yet very little overlap is observed with GFRα1+ spermatogonia. 
This places Sox3 expression within a very specific subset of Type A spermatogonia. 
Furthermore, we noted an increase in GFRα1+ spermatogonia in Sox3 null mouse 
testis at P7, indicating that without SOX3, Type A spermatogonia fail to differentiate 




2.2.1 CHARACTERISING THE GLOBAL TRANSCRIPTIONAL 
MECHANISMS OF SOX3 IN MOUSE TESTES 
In Manuscript II, “DNA binding profile of SOX3 in mouse testes”, we sought to 
examine the transcriptional role of SOX3 in a previously unexplored tissue. Whilst 
spermatogonial progenitor cells are unique in that they express only Sox3 and not 
Sox1 or Sox2, it is unknown whether SOX3 performs a different function in SPCs than 
it does in NPCs (Manuscript I). On one hand, the lack of functional redundancy 
should allow for easier identification of the role of SOX3 in SPCs, however SPCs may 
not provide significant insight into understanding SOX3s function in neural cell 
types. In this manuscript we assess SOX3’s genome wide binding sites with ChIP-
seq, using our highly specific SOX3 antibody in testes from P7 wild type mice. 
Manuscript II identifies 778 SOX3 bound regions, which through gene ontology 
analyses appear to implicate SOX3 in histone regulation during spermatogenesis. 
We also highlight that this may be SOX3’s core role, as many of these histone 
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SOX3 is a transcription factor expressed within the developing and adult nervous 
system where it mostly functions to help maintain neural precursors. Sox3 is also 
expressed in other locations, notably within the spermatogonial stem/progenitor 
cell population in postnatal testis. Independent studies have shown that Sox3 null 
mice exhibit a spermatogenic block as young adults, the mechanism of which 
remains poorly understood. Using a panel of spermatogonial cell marker genes, 
we demonstrate that Sox3 is expressed within the committed progenitor fraction of 
the undifferentiated spermatogonial pool. Additionally, we use a Sox3 null mouse 
model to define a potential role for this factor in progenitor cell function. We 
demonstrate that Sox3 expression is required for transition of undifferentiated cells 
from a GFRα1+ self-renewing state to the NGN3+ transit-amplifying compartment. 
Critically, using chromatin immunoprecipitation, we demonstrate that SOX3 binds 
to a highly conserved region in the Ngn3 promoter region in vivo, indicating that 
Ngn3 is a direct target of SOX3. Together these studies indicate that SOX3 functions 





SOX3 is a member of the SOX (Sry-related HMG box) family of transcription factors 
(TFs), of which there are 20 members in mammals. SOX TFs are expressed within 
many tissues of the mouse embryo and regulate a range of important cellular 
activities including self-renewal, specification and differentiation [164,165]. SOX TFs 
bind to variants of the SOX consensus motif (A/TA/TCAAA/TG) via a highly 
conserved HMG domain that shares at least 50% sequence identity with the 
founding member SRY. Sox1, Sox2 and Sox3 have high similarity across their entire 
open reading frame and together comprise the SoxB1 subgroup. SoxB1 genes are 
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expressed in NPCs throughout the entire vertebrate neuroaxis and are generally 
down regulated during differentiation [59,93]. Loss-of-function and overexpression 
experiments in a range of vertebrate systems indicate important and overlapping 
roles for SOXB1 factors in the generation and maintenance of neural 
stem/progenitor cells [92,115,117,166]. SOX3 is also expressed in progenitor cells 
outside of the nervous system, including the postnatal testis. However, the role of 
SOX3 in stem/progenitor cell maintenance in these tissues is less well understood. 
 
Spermatogenesis is the fundamental biological process required for the generation 
of sperm from progenitor cells via mitosis, meiosis, and a complex program of 
cellular differentiation. Importantly, in mammals, as in many other animals, 
sustained spermatogenesis in the adult is dependent on a resident population of 
germline cells with self-renewal potential. In the mouse testis, this stem cell activity 
is contained within a heterogeneous population of germ cells known as 
undifferentiated spermatogonia that develop from gonocytes (foetal germ cells) 
during the first week of postnatal development. The undifferentiated pool is located 
in the basal layer of the seminiferous tubules, and is composed of cells of distinct 
topologies; isolated type A-single spermatogonia (As) and interconnected chains of 
2 or more cells formed from incomplete cytokinesis during cell division referred to 
as A-paired (Apr) and A-aligned (Aal) spermatogonia, respectively[142]. Upon 
commitment to differentiate, cells convert to type A1 spermatogonia, which then 
undergo a series of rapid mitotic divisions prior to meiosis and sperm formation. 
Besides having distinct cell division kinetics, differentiating spermatogonia can be 
distinguished from undifferentiated cells by expression of the receptor tyrosine 
kinase c-KIT plus DNA methyltransferases 3A and 3B (DNMT3A/DNMT3B) [156,167].  
 
All cells within the undifferentiated pool may possess self-renewal potential [168]. 
However, only a small subset of this population act as stem cells in the steady state 
tissue, with a majority of undifferentiated cells being primed to differentiate and 
therefore acting as committed progenitor/transit-amplifying cells [169]. The fate 
tendencies of undifferentiated cells correlate with gene expression patterns and 
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chain length. Specifically, steady-state stem cells express Gfra1, encoding a co-
receptor for the key niche-derived growth factor glial cell line derived neurotrophic 
factor (GDNF) and exist primarily as As, Apr and some short-chained Aal cells [153]. 
A primitive subset of GFRα1+ As and Apr spermatogonia with potent stem cell activity 
and marked by transcription factors EOMES and PDX1 has also recently been 
described [170,171]. In contrast, the majority of Aal spermatogonia express Ngn3 and 
Rarg and are usually differentiation-committed [161,162,172,173]. Interestingly, 
lineage-tracing studies have demonstrated that a small fraction of the NGN3+ 
population is still capable of forming stable long-lived clones within the testis [161]. 
Moreover, NGN3+ Aal cells occasionally fragment to shorter chains plus As cells and 
may revert gene expression patterns to a GFRα1+ state, demonstrating the 
dynamic nature of the stem cell pool [159,171]. This limited contribution of NGN3+ 
cells to the steady-state self-renewing pool is also enhanced under conditions of 
tissue regeneration [161]. However, in contrast to GFRα1+ spermatogonia, 
NGN3/RAR+ undifferentiated cells are sensitive to retinoic acid, a key endogenous 
differentiation stimulus, which promotes a differentiation-committed fate [162].  
 
As transition from the GFRα1+ to NGN3+ state switches the predominant fate of 
undifferentiated cells from self-renewal to differentiation, it must be tightly 
regulated to ensure tissue homeostasis. A limited number of factors have been 
directly implicated in regulation of this transition. For instance, the SOHLH1/2 
transcription factors and mTORC1-signalling pathway promote exit from a GFRα1+ 
state while the NANOS2 RNA binding protein prevents the GFRα1+ to NGN3+ 
transition via direct inhibition of both Sohlh2 mRNA translation and mTORC1 
activation [173-177]. Despite the importance of such factors and pathways in fate 
transitions within the undifferentiated pool, the relevant downstream effectors 
remain poorly characterised.  
 
Sox3 is one of a number of identified target genes of SOHLH1/2 within the testis 
and is reported to play a role in spermatogenesis, whereby Sox3 deletion causes a 
block in spermatogenesis that is most severe in mice bred on the C57Bl/6 genetic 
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background [108,109,175]. However, the exact nature of this spermatogenic block 
and the underlying molecular mechanisms are not fully understood. Through use 
of a Sox3-GFP knock-in mouse model we now confirm that Sox3 is specifically 
expressed within the committed progenitor fraction of the undifferentiated pool 







4.3.1 SOX3 EXPRESSION IS RESTRICTED TO COMMITTED SPERMATOGONIAL PROGENITOR 
CELLS 
Previous studies have shown that Sox3 expression in the testis is restricted to 
spermatogonial populations within the basal layer of the seminiferous tubules 
[92,108,109]. Through use of a SOX3-specific antibody [93], we confirmed by 
immunofluorescence (IF) analysis that SOX3 protein is restricted to spermatogonia 
of wild type (WT) adult testis (Fig. 1A). Spermatogenesis occurs in a coordinated, 
cyclic process that can be divided into 12 stages in the mouse. Sections of tubules 
at a given stage contain defined populations of spermatogonia, spermatocytes 
and developing spermatids at distinct differentiation and maturation steps 
[142,178]. Importantly, SOX3-positive spermatogonia were present at all stages of 
the seminiferous epithelium cycle, indicating that Sox3 is expressed in the 
undifferentiated population (Fig. 1B). Moreover, spermatogonia expressing Sox3 
displayed low levels of Cyclin D1 (Ccnd1), a marker predominantly expressed by 
differentiating spermatogonia (Fig. 1A) [155,179]. In contrast to the stage-
independent presence of SOX3-positive cells, spermatogonia expressing CCND1 
were predominantly found in stage I-VI tubules in which populations of 
differentiating spermatogonia are the most abundant (Fig. 1B).  
In order to better define the identity of the SOX3-positive population we next 
performed IF analysis of prepubertal, WT postnatal day 7 (P7) testis, which is 
relatively enriched in undifferentiated spermatogonia. Comparison of Sox3 
expression with that of promyelocytic leukaemia zinc finger (Plzf), which is 
expressed throughout the undifferentiated pool [154,180], revealed extensive 
overlap (Fig. 1C,D). Analysis of adult and juvenile testis therefore suggested that 
SOX3 is broadly expressed in the undifferentiated population. To investigate this 
further, we compared SOX3 expression with that of GFRα1, a marker for the self-
renewing fraction of undifferentiated spermatogonia [153]. In comparison to the 
pronounced co-expression of SOX3 with PLZF, we found a limited overlap in 
expression of SOX3 and GFRα1 (Fig. 1E), suggesting that within the undifferentiated 
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population, SOX3 is preferentially expressed in the committed progenitor fraction 
[175]. 
To further characterise the expression of SOX3 in spermatogonia, we also 
performed IF analysis on cultures of undifferentiated spermatogonia derived from 
juvenile WT mice [180]. SOX3 expression was compared to that of PLZF and the 
transcription factor SALL4, which is expressed in undifferentiated and 
differentiating spermatogonia [181]. Consistent with previous studies, PLZF and 
SALL4 were expressed by essentially all cells within the colonies of cultured cells 
(Fig. 1F)[181]. In contrast, SOX3 expression was clearly heterogeneous. Given that 
these cultures are considered to contain a mix of both stem and committed 
progenitor cells[182], our data support the conclusion that SOX3 expression is 
restricted to a subset of undifferentiated cells, likely representing the committed 






Figure 1. SOX3 expression is found within a subset of undifferentiated 
spermatogonia. (A) IF of adult testis cross sections showing expression of SOX3 is 
restricted to spermatogonia. Note the staining in Leydig cells is non-specific. (B) 
The number of SOX3+ spermatogonia remains constant, independent of the stage 
of spermatogenesis, whereas CCDN1+ spermatogonia are more prevalent in stage 
I-VI tubules. (C) IF of SOX3 and PLZF in P7 testis cross sections demonstrates an 
extensive overlap, with only a few SOX3-/PLZF+ spermatogonia present. (D) 60X 
magnification of white box in (C) highlighting variations in PLZF expression from 
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low (*) to high. (E) IF of SOX3 and GFR1 in P7 testis cross-sections showing limited 
overlap of expression. (F) IF of SOX3, PLZF and SALL4 in cultures of undifferentiated 
spermatogonia derived from juvenile mice, PLZF and SALL4 are detected within 
essentially all cells, while SOX3 is only present within a subset of cells. Scale bars 




Notably, from IF analysis of P7 testis sections, we confirmed that essentially all 
SOX3+ cells were positive for spermatogonial marker SALL4 but that Sox3 
expression was restricted to a subset of the SALL4+ population (32.7  8.0% of 
SALL4+ cells were SOX3+, mean  s.e.m, n = 3 mice, >70 tubule cross-sections scored 
per sample) (Figure 2A). In contrast, no overlap in expression was found between 
SOX3 and EOMES, a marker of the most primitive cells within the GFRα1+ self-
renewing fraction (Figure 2B) [170,171]. Combined, our results indicate that Sox3 
expression delineates a subset of differentiation committed spermatogonia.  
Finally, to confirm the expression pattern of SOX3 within mature stem and 
progenitor spermatogonial populations, we compared its expression with that of a 
number of distinct spermatogonial markers by wholemount analysis of adult 
seminiferous tubules (Fig. 3). Importantly, IF for GFRα1 and SOX3 in adult tubules 
demonstrated that expression of these genes largely marked distinct 
spermatogonial populations, in agreement with our previous results (Fig. 1D). GFRα1 
primarily labelled As and Apr cells while SOX3 was present in GFRα1-negative SALL4-
positive Aal (Fig. 3A). Antibodies to GFRα1 and SOX3 used in wholemount analysis 
are both raised in goat and are visualized in the same fluorescence channel but 
can be distinguished by cell membrane vs. nuclear staining pattern (Fig. 3A and S1). 
Rather, we found that SOX3 was co-expressed in chains of undifferentiated 
spermatogonia plus cells at early differentiation stages with genes that mark 
committed progenitor fractions, including RAR and LIN28A (Fig. 3B,C and data not 
shown) [162,183]. In contrast, chains of c-KIT+ spermatogonia at mid-to-late stages 
of differentiation (A3 to B) expressed low or undetectable levels of SOX3 (Fig. 3D) 
[155,156,167,171].  
Taken together, our data demonstrate that SOX3 expression is selectively 
upregulated upon transition from the self-renewing to the differentiation-primed 
progenitor state within the undifferentiated population of both juvenile and adult 





Figure 2. Characterising the expression of SOX3 in juvenile testis. (A,B) 
Representative IF analysis of SOX3 and markers of spermatogonia (SALL4) and 
primitive self-renewing cells (EOMES) in testis sections from P7 mice (n = 3 mice). 
Insets show higher magnification details of indicated regions. Arrowheads indicate 





Figure 3. Characterising the expression of SOX3 in adult testis. Assessing co-
expression of SOX3 with a panel of undifferentiated and differentiated 
spermatogonia cell markers in adult seminiferous tubules by wholemount IF. SOX3 
shows limited overlap in expression with stem cell-associated marker GFR1 (A) but 
is co-expressed with progenitor markers RAR (B) and LIN28A (C) within the 
undifferentiated pool. SOX3 is expressed at low levels or is undetectable in mid-late 
stage differentiating spermatogonia marked with c-KIT (D). Note that antibodies to 
SOX3 and GFR1 are both raised in goat and detected in the same fluorescence 
channel. Cell staining patterns are used to distinguish GFR1 (cell membrane) and 
SOX3 (nucleus). Selected undifferentiated cells and stages of tubules are indicated. 
Representative images are shown (n = 4 mice). Scale bars are 50m.  
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4.3.2 EARLY POSTNATAL DEFECT IN 129/SVJ SOX3 NULL TESTES 
Spermatogenesis phenotypes have been reported in Sox3 null mice on mixed and 
C57BL/6 inbred backgrounds [92,107,109]. To investigate whether spermatogenesis 
is also affected on a 129/Svj inbred background, Sox3 null mice were backcrossed 
and examined for testis abnormalities. No significant difference in testis weight or 
morphology (Fig. S2A,B) was detected in Sox3 null mice at postnatal day 7 (P7; Fig. 
S2 A,B; WT = 5.3 ± 0.2mg; KO = 5.1 ± 0.4mg). Histological analysis also failed to reveal 
any gross defects at this stage (Fig. S3). In contrast, Sox3 null testes were 
significantly smaller than WT testis at P14, P21 (Fig. S2C-F) and at 6 months of age. 
Histological analysis revealed an abundance of empty tubules in Sox3 null testes 
consistent with previous reports [92,107,109] (Fig. S3E,F). To address whether 
elevated programmed cell death might account for testis hypoplasia in Sox3 null 
mice, we performed TUNEL staining on testis sections. No difference in the number 
of apoptotic cells was observed between WT or Sox3 null testis at P7 (Fig. S3C,D). 
To further investigate the cellular mechanism that underpins the spermatogenic 
block in Sox3 null testes, we compared expression of spermatogonial cell markers 
in WT and Sox3 null testis at P7. We reasoned that although Sox3 null testes were 
not hypoplastic at this stage, the primary molecular/cellular defect(s) underpinning 
the defect would likely be present, given that Sox3 is expressed at this time point 
(Fig. 1). Expression of Oct4/Pou5f1, Plzf, Id4 and Ecad were not significantly different, 
suggesting that the number of Type A spermatogonia is not grossly affected by 
the absence of Sox3 [157,180]. Further, expression of these markers was not 
significantly altered in KO testis at P14, P21 and P28. In contrast, Ngn3, a marker of 
committed undifferentiated spermatogonia, was substantially reduced at P7 (Fig. 
4A) and remained significantly lower throughout postnatal testis development (P14, 
P21 and P28) (Fig. 4B, C and D), as observed previously in B6 KO mice [108]. 
Conversely, expression of Gfra1, a marker for the self-renewing fraction of 
undifferentiated spermatogonia, was significantly higher in Sox3 null testis 
compared to WT (Fig. 4). Gfra1 expression remained significantly elevated at P14 
and P21 although it had apparently normalised by postnatal week 4 (Fig. 4B, C and 
D). Interestingly, expression of Id4, a marker associated with transplantable stem 
cell activity that is detected in a subset of the GFRα1-positive population in adults, 
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but is more broadly expressed by spermatogonia during postnatal development, 
was not significantly altered by loss of Sox3 (Fig. 4A-D) [184]. While the significance 
of unaltered Id4 expression is unclear, the increase in Gfra1 and reduction in Ngn3 
expression in response to Sox3 deletion suggests a relative increase in self-
renewing spermatogonial subsets and a corresponding decrease in differentiation-
primed progenitors.  
To confirm these observations in the mature spermatogonial pool, we isolated 
undifferentiated cells (EpCAM+ α6-integrin+ c-KIT–) from wildtype control and Sox3 
KO adults and analysed gene expression by RT-qPCR (Fig. 5) [185]. Within the 
EpCAM+ germ cell fraction of Sox3 KO testis a significantly greater proportion of 
cells were in the α6-integrin+ c-KIT– undifferentiated cell gate compared to controls 
(Fig. 5B,C), suggesting that spermatogonial differentiation was disrupted in the 
Sox3 KO and undifferentiated cells accumulated with age. In agreement with 
analysis of total testis extracts during postnatal development, Sox3 KO adult 
undifferentiated spermatogonia exhibited significantly lower expression of Ngn3 
while other stem and progenitor-associated markers were mostly comparable to 
controls. Expression of Gfra1 was increased in Sox3 KO undifferentiated cells, 
although not significantly so (P = 0.0569), consistent with previous results (Fig. 4 and 
5D). Combined, our results support the involvement of SOX3 in stem-to-progenitor 
transition in the male germline and specifically link SOX3 with expression of Ngn3, 






Figure 4. Comparative analysis of Sox3-/Y and WT testis gene expression. 
Expression analysis of spermatogonia cell markers Sox3, Gfra1, Ngn3, Oct4, Plzf, Id4 
and E-Cad in P7 (A), P14 (B), P21(C) and P28 (D) testes. n = 4 for each genotype, 






Figure 5. Isolation and analysis of Sox3 null adult undifferentiated 
spermatogonia. (A,B) Flow-sorting strategy for isolation of undifferentiated 
spermatogonia (EpCAM+ c-KIT– 6-integrin+) for gene expression analysis. 
Percentages of cells within gates are indicated. (C) Graph shows percentage of 
EpCAM+ germ cells within c-KIT– 6-integrin+ undifferentiated cell gate from flow 
cytometry analysis of wildtype and Sox3 null adult testis of A and B. Mean values  
s.e.m. are shown (n = 5 wildtype and n = 6 Sox3 null mice). Significance was 
determined by two-tailed unpaired t-test, P < 0.01 (**). (D) RT-qPCR analysis of 
sorted undifferentiated spermatogonia (EpCAM+ c-KIT– 6-integrin+) from 
wildtype and Sox3 null adult testis. Expression levels are corrected to -actin and 
normalized to a control sample. Mean values  s.e.m. shown (n = 5 wildtype and n = 
6 Sox3 null mice). Significance was determined by two-tailed unpaired t-test and 




4.3.3 SOX3 promotes exit from the GFR1-positive spermatogonial state 
T To further investigate the cellular mechanism that underpins elevated expression 
of Gfra1 in Sox3 null testis, we first performed IF analysis of P7 testis sections.  
Importantly, we observed a significant increase in the total number of GFRα1 
positive cells per tubule cross-section in Sox3 null testis compared to WT testis 
(mean of 12.3 ± 0.28 versus 6.2 ± 0.19 cells/tubule, Р< 0.0001; Fig. 6A). This relative 
expansion of the GFRα1-positive population may suggest that Sox3 deficiency 
resulted in a differentiation block at the stem-to-progenitor cell transition or 
increased self-renewing divisions of Gfra1-expressing cells. Alternatively, given the 
dynamics of cell transitions within the undifferentiated compartment [159], it might 
represent an inability to maintain a stable progenitor population and increased 
reversion of committed cells to a self-renewing state.  
To investigate these distinct possibilities, we took advantage of a unique feature of 
our Sox3-deficient model. Namely, that Sox3 deletion is accompanied by insertion 
of a GFP reporter gene into the Sox3 locus [92]. Analysis of GFP expression in Sox3 
null testis therefore allows identification of committed progenitor populations that 
are usually marked by Sox3 expression in the WT setting. From WT and Sox3 null 
testis we therefore scored the number of uncommitted stem cells (GFRα1+/SOX3- 
and GFRα1+/GFP- respectively), transitional/early committed progenitor cells 
(GFRα1+/SOX3+ and GFRα1+/GFP+) and committed progenitor cells (GFRα1-
/SOX3+ and GFRα1-/GFP+) (Fig. 6B). Importantly, no significant difference was 
detected in the total number of cells expressing these distinct marker combinations. 
However, significant differences were detected in the relative abundance of two 
subpopulations. Firstly, the number of cells that exhibited a committed progenitor 
phenotype (GFRα1-/GFP+ vs. GFRα1-/SOX3+) was significantly reduced in Sox3 null 
testes as compared to WT controls. Secondly, there was a significant increase in 
the number of uncommitted (GFRα1+/GFP- vs. GFRα1+/SOX3-) stem cells in the 
Sox3 null testes. While populations of transitional cells (GFRα1+/GFP+ vs. 
GFRα1+/SOX3+) were not significantly altered upon loss of Sox3 at this early 
postnatal age, transitional stem-progenitor cells were found to accumulate in Sox3 
null adults (see below). Our results indicate that while the total population of stem 
and progenitor spermatogonia is relatively unaffected in the juvenile Sox3 null 
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testis, there is a shift in balance from stem to committed progenitor cell phenotype. 
This suggests that Sox3 promotes the stable transition from stem to progenitor cell 
states and is consistent with changes in Gfra1 and Ngn3 expression in Sox3 null 





Figure 6. Increased number of GFR1+ spermatogonia in Sox3-/Y testis. (A) 
Frequency plot showing more GFR1+ cells per tubule in Sox3 null testis cross-
sections (12.3+/- 0.28) compared to WT (6.2+/-0.19), <0.0001. (B) Cell counts of the 
different spermatogonia cell identities as marked by SOX3/GFP and or GFR1 
staining. IF of WT testis cross sections at P7 (C), and Sox3 null testis sections (D), 
staining for SOX3 (red) and GFR1 (green). Minimum 10 fields of view per counted 
section, 3 sections per testis, n=3 for each genotype, not significant (ns), <0.05 (*), 
<0.0001(****) as determined by Mann-Whitney test. Data represented as means.d., 




To further investigate this phenotype and the consequences of inefficient stem to 
progenitor cell conversion on the spermatogenic pathway, we analysed Sox3 
deficient adult testis by whole mount IF of seminiferous tubules (Fig. 7A). In this 
analysis, SALL4 was used as a marker of both undifferentiated and differentiating 
spermatogonia, while expression of DNMT3B identified differentiating 
spermatogonia [167,181]. The distinct stages of the seminiferous tubule areas were 
then defined according to the differentiation stage of resident spermatogonial 
populations as described [178,186]. Consistent with analysis of juvenile testis 
sections, the basal layer of adult Sox3 null tubules demonstrated pronounced 
increases in the density of GFRα1-positive cells throughout the seminiferous 
epithelium cycle (Fig. 7A). Notably, while in WT tubules GFRα1-positive cells were 
most frequently present as As and Apr, in Sox3 null testis they were often found as 
Aal chains of 4 or more cells. The increased GFRα1-positive chain length in Sox3 null 
testis was accompanied by evidence of disruption to the spermatogonial 
differentiation pathway. Specifically, at stages II-V, when WT tubules contained 
abundant populations of GFRα1-/SALL4+/DNMT3B- Aal cells; Sox3 deficient Aal often 
abnormally retained Gfra1 expression (Fig. 7A). Moreover, between stages V-XI, 
during which essentially all WT Aal cells initiate differentiation and generate GFRα1-
/SALL4+/DNMT3B+ differentiating A-type spermatogonia, a substantial fraction of 
Aal cells in the Sox3 deficient testis persisted in a GFRα1+/SALL4+/DNMT3B- 
undifferentiated state (Fig. 7A). Consequently, the density of differentiating 
spermatogonia at times appeared lower in Sox3 null tubules as compared to WTs.  
This data indicates that Sox3-deficient Aal cells, while morphologically resembling 
differentiation-primed undifferentiated spermatogonia do not appropriately down-
regulate GFRα1, a key functional marker of the stem cell state [187]. Moreover, these 
GFRα1+ Aal cells subsequently enter the differentiation pathway less efficiently than 
their WT GFRα1– Aal counterparts. Consistent with our observations, the majority of 
GFRα1+ Aal that accumulated in Sox3 null adults did not express RAR (Fig. 7B), a 
marker of committed progenitors required for differentiation commitment (Gely-
Pernot et al., 2012; Ikami et al., 2015). Interestingly, however, a minor subset of 
GFRα1+ Aal cells in the knockout did express RAR, indicating an accumulation of 
transitional undifferentiated cells exhibiting both stem and progenitor 
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characteristics. Such a stem-progenitor transitional state is rarely detected in WT 
adult testis, as is presumably short-lived but persists in the absence of Sox3, as 
undifferentiated cells appear unable to adopt a stable committed progenitor state 
(Fig. 7B). Note that RAR+ GFRα1– progenitors were still found in Sox3 null testis 
indicating that stem to progenitor conversion was not completely abrogated, in 




Figure 7. Analysis of Sox3 null adult seminiferous tubules by whole mount IF. 
Wholemount IF analysis of WT and Sox3 knockout adult seminiferous tubules for 
SALL4, DNMT3B, GFR1 (A) and GFR1, RAR, DNMT3A (B) at the indicated 
spermatogenic stages. Grayscale panels show individual immunostaining within the 
indicated area. Arrowheads in (B) indicate GFR1+/RAR+ transitional cells found 
relatively frequently in Sox3 knockout tubules but rarely in WT samples. Scale bars 




4.3.4 NGN3 IS A DIRECT TARGET OF SOX3 
Given the near complete failure to activate Ngn3 expression in Sox3 null postnatal 
testes, we investigated the possibility that Ngn3 can be a relevant target of SOX3 
in germline cells. Previous ChIP-Seq studies of neural progenitors[55,188] identified 
a SOX3 binding peak and single SOX consensus motif (SOCM) approximately 
500bp upstream of the transcriptional start site of Ngn3 (Fig. 8A). This genomic 
region is highly conserved in mammals suggesting it may function as an enhancer. 
To investigate SOX3 binding to this region, we performed SOX3 ChIP-PCR on P7 
mouse testis. Significant enrichment of SOX3 binding to this region was detected, 
suggesting that Ngn3 is directly activated by SOX3 in vivo (Fig. 8B). As a positive 
control, we confirmed that SOX3 in testis cells also binds the SOX3 target gene Dbx1 





Figure 8. Ngn3 is a direct SOX3 target gene in spermatogonia. UCSC Genome 
Browser view of published SOX3 ChIP-seq data[188] from NPCs showing a SOX3 
binding site within the upstream promoter region of Ngn3 (A). ChIP-PCR for SOX3 
in P7 testis (B), demonstrating SOX3 binding upstream of the Ngn3 promoter 
(Ngn3), <0.05 (*), <0.01 (**) as determined by t-test, data represented as 
means.d. –ve control represents a site within Notch1 known not to bind SOX3, +ve 
control represents a site within intron 2 of Dbx1 previously validated as a binding 






Previous studies have shown that SOX3 is expressed in Type A spermatogonia 
[92,108,109]; however, these range from stem cells through to committed 
progenitors and overtly differentiating cells and it was unclear how the expression 
and function of SOX3 related to this progression. Here we show extensive overlap 
between SOX3 and multiple markers of undifferentiated spermatogonia (PLZF, 
LIN28A and SALL4) indicating that Sox3 is expressed within this compartment. 
Comparison of SOX3 with spermatogonial stem cell markers GFRα1 and EOMES 
revealed limited or no overlap respectively, indicating that the SOX3 negative 
spermatogonial population are bona fide stem cells. Taken together, we conclude 
that Sox3 is not expressed by the steady-state stem cell population (GFRα1-
positive) but is rapidly upregulated during initial differentiation commitment of 
these cells. The lack of Sox3 expression in DNMT3A/B, c-KIT and CCND1 positive A3 
to B spermatogonia indicates that Sox3 is subsequently downregulated at later 
stages of differentiation. Thus, Sox3 expression closely mirrors that of Ngn3, a key 
marker of committed progenitor spermatogonia [190]. Definitive identification of 
Ngn3 expressing cells in vivo is hampered by the lack of a specific antibody and 
therefore requires knock-in GFP reporter mice. Therefore, given the availability of 
commercial specific antibodies, SOX3 provides a useful alternative marker for 
committed type A spermatogonia. 
 
Within the undifferentiated spermatogonial pool, GFRα1+ cells have a high self-
renewal potential while NGN3+ cells are primed to differentiate [153,159]. The 
distinct fates of these undifferentiated cell subsets are defined by relative sensitivity 
to retinoic acid (RA), a key endogenous regulator of spermatogonial differentiation. 
Specifically, NGN3+ cells are responsive to RA due to expression of the RA receptor 
RAR, while GFRα1+ cells lack RAR expression and are consequently unresponsive 
to RA [162,173]. Combined, our data demonstrate that SOX3 is critically required for 
formation of GFRα1-/NGN3+ differentiation-primed progenitors from the 
GFRα1+/NGN3- stem cell pool. Moreover, we find that Sox3 is specifically 
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upregulated during this stem-to-progenitor transition and SOX3 directly targets 
Ngn3 (see below). This suggests that SOX3 plays a central and cell-autonomous 
role in promoting exit from a GFRα1+ stem cell state. Sox3 deletion therefore results 
in an accumulation of GFRα1+ cells and a substantially reduced capacity to 
generate RA-sensitive, differentiation-primed GFRα1- progenitors within the 
undifferentiated pool. Consequently, this leads to a reduction in production of 
differentiating spermatogonia and ineffective or blocked spermatogenesis (Fig. 9). 
In adults, loss of Sox3 was also accompanied by an accumulation of transitional 
undifferentiated cells expressing both stem and progenitor markers, reflecting 
inefficient stem to progenitor conversion.  
 
It is also possible that in the absence of SOX3, differentiation-primed GFRα1-
negative progenitors are still successfully generated within the undifferentiated 
pool but are not stably maintained and rapidly revert to a GFRα1+ state, mimicking 
the cellular dynamics observed during testis regeneration [159]. This possibility 
could be tested by fate-mapping progenitor populations upon Sox3 deletion, 
through use of Ngn3-CreER plus reporter lines or by developing an equivalent Sox3-
CreER transgenic model [161]. Based on current models [159,169], progenitor-to-
stem cell reversion upon Sox3 deletion would be predicted to be accompanied by 
fragmentation of longer undifferentiated progenitor chains back to As and Apr 
GFRα1+ cells. However, in the Sox3 null adult, we find GFRα1+ cell chain lengths to 
be increased compared to WT controls, arguing against this reversion model. 
Rather, our results suggest that the physiological process of differentiation priming 
that normally occurs as chain length increases within the undifferentiated pool 
does not occur in the Sox3 null testis (Fig. 8). Consequently, a large proportion of 
the Sox3-deficient Aal population abnormally retains gene expression patterns and 
properties of the stem cell state, including being refractory to differentiation stimuli 
such as RA. This GFRα1+ Aal population generally lacks expression of RAR, a marker 






Figure 9. Model of spermatogenesis in WT and Sox3 KO adult testis. GFR1 is 
found within the spermatogonial stem cell pool of WT testis, before being switched 
off as the cells progress into a progenitor cell state. Conversely, SOX3 is not found 
within the stem cell population and expression is switched on upon conversion into 
progenitor cells. SOX3+ progenitor cells differentiate and continue through the 
spermatogenesis pathway. Additional markers delineating the distinct 
differentiation stages of spermatogonia are indicated. In Sox3 knockout (KO) testis, 
the loss of SOX3 leads to an accumulation of GFR1+ cells, and a reduction in the 
capacity to form differentiation-primed GFR1- progenitor cells. This ultimately 
leads to a reduction in the production of differentiating spermatogonia. In adult WT 
testis, GFR1+ stem cells are mostly present as As and Apr while GFR1+ Aal cells are 
frequently found in Sox3 null testis. Stem-progenitor transitional Aal cells expressing 
both GFR1 and RAR also accumulate in Sox3 knockouts but are rarely found in 
WT tubules. We propose that SOX3 plays an essential role in efficient stem to 
progenitor conversion within the undifferentiated spermatogonial population.  
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We have provided evidence that Ngn3 is a direct target gene of SOX3 in 
spermatogonia. NGN3 is a prototypical marker of the committed progenitor state 
and knockdown of Ngn3 expression in cultured undifferentiated spermatogonia 
disrupts differentiation upon transplantation in vivo [159,191]. Therefore, the loss of 
Ngn3 expression upon Sox3 deletion may be responsible for reduced efficiency of 
the stem cell population to progress to a committed progenitor state. Collectively 
our data define the window in which SOX3 acts during spermatogenesis, as well as 
one critical direct target gene, Ngn3. Further studies of both the regulation and the 
role of SOX3 will help reveal how type A spermatogonia progress from stem cells 
to committed precursors and the degree to which these processes are shared 




4.5 MATERIALS AND METHODS 
 
4.5.1 ANIMALS 
Generation of the Sox3 null mice on a mixed genetic background (129 sv/eV, MF1, 
CBA and C57Bl/6) has been described previously [92]. Mixed background Sox3 null 
mice were crossed onto the 129/SvJ genetic background and mice from the F6 
generation or from a 129/SvJ, CBA mixed background were used in these studies.  
 
4.5.2 TESTIS HISTOLOGY AND IMMUNOFLUORESCENCE (IF) 
Testes were isolated and fixed in 4% formaldehyde overnight, followed by 
equilibration of tissues in 30% sucrose. Testis were set in OCT compound (Tissue-
Tek) and cryosectioned on a Leica CM1900 at 16μm thickness. For IF, sections were 
permeablised with 1% Triton in PBS for 10 minutes, blocked with 10% horse serum 
for 1 hour, followed by overnight incubation with primary antibodies overnight at 
4°C. Sections were washed with PBS and incubated in secondary antibody solution 
for 1-2 hours, washed in PBS, mounted in ProLong Gold Anitfade Mountant with DAPI 
(Life Technologies, P-36931) before being cover slipped. Images were captured on 
a Nikon Ti-E inverted microscope with NIS software (NIKON) using a 20x objective 
lens. For histology, sections were dehydrated in an increasing methanol series from 
10% to 100%. Sections were stained with haematoxylin and eosin. Whole mount IF 
of seminiferous tubules was performed as described [171,173].   
4.5.3 ANTIBODIES 
Antibodies are detailed previously [155,171,173,180,181], including α SOX3 (R&D 
Systems AF2569), DNMT3A (Novus Biologicals 64B1446), DNMT3B (Novus 
Biologicals 52A1018), c-KIT (Cell Signaling Technologies #3074), LIN28A (Cell 
Signaling Technologies #8641) and Cyclin D1 (Novus Biologicals SP4).  
4.5.4 TUNEL ASSAY 
TUNEL assays were performed as per manufacturer’s instructions (Roche, 
11684795910). Briefly, tissue was permeabilised in 0.1% Triton X-100 for 2 minutes on 
ice, washed twice with PBS, then incubated with TUNEL reaction mixture for 60 mins 
Page 91 
 
at 37C in a humidified chamber. Tissue was washed 3 times with PBS followed by 
mounting with ProLong Gold Anitfade Mountant with DAPI. 
4.5.5 QPCR 
RNA from testis of all mouse ages was extracted by mechanically dissociating 
tissue in Trizol (Life Technologies) for 10 minutes as per manufacturer’s instructions. 
RNA was run on a 1.5% RNase free agarose gel to assess integrity. cDNA was 
generated using the High Capacity RNA to cDNA kit (Life Technologies). Expression 
profiling was performed on four WT and four Sox3 null testes at each age, using B-
Actin and Eif4a as a reference genes. qRT-PCR was performed using Fast Sybr 
Green Master Mix (Life Technologies), and run on the ABI 7500 StepOnePlus system, 
all reactions were completed in triplicate. Isolation and gene expression analysis of 
adult undifferentiated spermatogonia was performed as described [185]. 
4.5.6 PRIMER SEQUENCES 
qPCR primers used for gene expression analyses were as follows: 
Sox3: F 5’-GAACGCATCAGGTGAGAGAAG-3’, R 5’-GTCGGAGTGGTGCTCAGG-3’ 
Gfra1: F 5’-ATCGGGCAGTACACATCTCTG-3’, R 5’-TGTGGTTATGTGGCTGGAGG-3’ 
Plzf: F 5’-CCTGGACAGTTTGCGACTGA-3’, R 5’-GCCATGTCCGTGCCAGTAT-3’ 
Ngn3: F 5’-CCCCAGAGACACAACAACCT-3’, R 5’-AGTCACCCACTTCTGCTTCG-3’ 
Oct4: F 5’-CCCAGGCCGACGTGG-3’, R 5’-GATGGTGGTCTGGCTGAACAG-3’ 
Id4: F 5’-CTCACCCTGCTTTGCTGAGA-3’, R 5’-TCACCCTGCTTGTTCACGG-3’ 
E-Cad: F 5’-TTGCAAGTTCCTGCCATCCT-3’, R 5’-CATCATCTGGTGGCAGCAG-3’ 
-Actin: F 5’-CTGCCTGACGGCCAGG-3’, R 5’-GATTCCATACCCAAGAAGGAAGG-3’ 
Eif2: F 5’-TGATGGCACTGGCCCCAACAT-3’, R 5’-GCGCCCTCCTTAGTAGCCCAC-3’ 
 
qPCR primers used for ChIP-PCR analyses were as follows: 
Ngn3: F 5’-GAGAGTTGCTGGGACTGAGC-3’, R 5’-AGCTGGATTCCGGACAAAG-3’ 
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Dbx1: (+ve control) F 5’-CTTTGGTCTCCACAAGCTTTCT-3’,  
R 5’-GAATGTGGCCTTTAACAACTCAC-3’ 




P7 mouse testis were extracted and tissue was mechanically disassociated in 1% 
formaldehyde for 8 minutes at room temperature, followed by neutralisation with 
125mM glycine for 5 minutes at 4°C. Cells were lysed followed by sonication 
(Bioruptor, Diagenode) for 15 minutes with 30s cycling pulses on ice. SOX3 bound 
chromatin was immunoprecipitated by a goat polyclonal antibody raised against 
human SOX3 (R&D systems, AF2569). DNA was recovered after reversing crosslinks 
and purified by PCR clean-up kit (QIAGEN). Three independent ChIP samples were 
generated each from the material of 4 testis. Each sample was analysed by qRT-
PCR as described above, using 1% input as a reference and ChIP samples from Sox3 
null testis as a negative control.  
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4.9 SUPPLEMENTARY FIGURES 
 
Figure S1. Characterising expression pattern of SOX3 in adult testis. 
Wholemount IF analysis of adult seminiferous tubules demonstrating distinct 
subcellular localisation patterns of GFR1 (A) (cell membrane) and SOX3 (B) 
(predominantly nuclear) within undifferentiated spermatogonia. Demonstrates 
single stain antibody staining controls for GFR1 + SOX3 co-stain within same 
fluorescence channel (antibodies are both raised in goat). Spermatogonia are 
counterstained with SALL4. Selected undifferentiated cells and stages of tubules 






Figure S2. Comparison of whole Sox3 -/Y testes with WT mouse testes. No 
difference was observed in either size (A) or weight (B) of Sox3-/Y testes at P7. 
Sox3-/Y testes appear smaller at both P14 (C) and P21 (E), and weigh significantly 





Figure S3. Testes morphology.  Representative H&E images of P7 WT (A) and Sox3 
null (B) testes Adult testes, indicating a grossly normal phenotype. TUNEL assay on 
P7 WT (C) and Sox3 null (D) testis, showing no difference in amount of cell death. 
Representative H&E images of adult WT (E) and Sox3 null (F) testes sections 
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5.1 ABSTRACT 
Spermatogenesis is the male version of gametogenesis, where germ cells are 
transformed into haploid spermatozoa through a tightly controlled series of 
mitosis, meiosis and differentiation. This process is reliant on precisely timed 
changes in gene expression controlled by a number of different hormonal and 
transcriptional mechanisms. One important transcription factor is SOX3 which is 
transiently expressed within the uncommitted spermatogonial stem cell population 
in the testes. Loss of Sox3 in mouse testes results in a block in spermatogenesis, 
leading to infertility or subfertility. However, molecular role of SOX3 during 
spermatogonial differentiation remains poorly understood because the genomic 
regions targeted by this transcription factor have not been identified. To address 
this issue, we used ChIP-seq to identify and characterise the endogenous genome 
wide binding profile of SOX3 in mouse testes at post-natal day 7. As we have shown 
previously in neural progenitor cells, Ngn3 is directly targeted by SOX3 in 
spermatogonial stem cells, albeit via a different binding site in the Ngn3 promoter. 
We also implicate SOX3 for the first time in direct regulation of histone gene 
expression and demonstrate that this function is shared by both neural progenitors 
and testes, and with another important transcription factor required for 
spermatogenesis, PLZF. Altogether, these data provide new insight into the function 




The SOX family of transcription factors (TF) are widely expressed during 
embryogenesis and play a role the development of most, if not all organs [164,165]. 
The SOXB1 family comprises three members - Sox3, along with the closely-related 
genes Sox1 and Sox2. SOXB1 TFs have been shown to act redundantly in central 
nervous system (CNS) development, where they act to inhibit differentiation of 
neural progenitor cells (NPC) [59]. Expression of the SOXB1 TFs overlap extensively, 
particularly within NPCs of the developing mouse CNS [60]. Despite this overlap, 
Sox3 exhibits a small number of unique zones of expression. Interestingly, 
development of these unique zones is compromised in Sox3 null mice, resulting in 
aberrant pituitary formation, corpus callosum defects and impaired 
spermatogenesis [92,107-109,120].  
Within the testes, Sox3 is the only SOXB1 gene expressed within the undifferentiated 
pool of spermatogonial stem cells (SSCs) (D McAninch, JA Mäkelä, HM La, JN 
Hughes, R Lovell-Badge, RM Hobbs, & PQ Thomas, manuscript under review) 
[92,108,109]. Sox3 null mice exhibit a transient block in spermatogenesis resulting in 
a lack of mature sperm and reduced fertility [108]. While this phenotype has been 
reported in two independently generated Sox3 null mouse models, the function of 
SOX3 in spermatogonial stem cells has not yet been fully elucidated [107].  
Spermatogenesis is a complex biological process that drives the differentiation of 
SSCs into mature sperm, via a tightly controlled combination of mitosis and meiosis. 
Sustained spermatogenesis occurs throughout the adult life of mammals. Many 
genes, including Sox3 (as detailed above), Ngn3 and Plzf are required for successful 
completion of spermatogenesis [155,161]. Plzf is a zinc finger TF with transcriptional 
repressor and activator activity depending on the cellular context [192]. Plzf is 
expressed within As, Apr and Aal spermatogonia [154,155] and is proposed to maintain 
SSCs in an undifferentiated progenitor like state [193]. Ngn3 is basic helix-loop-helix 
TF expressed within late committed SSCs and is required to promote their 
differentiation into Type 1 spermatogonia [194].   
A significant amount of chromatin remodeling occurs throughout spermatogenesis, 
whereby standard histones are removed and replaced by testes-specific histone 
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variants. The testes-specific histones are subsequently replaced by protamines, an 
alternative form of chromatin condensing protein [195], allowing for tighter 
compaction of the nucleus. Various knockout studies performed in mice have 
shown that altered regulation of histone and protamine genes causes defects in 
spermatogenesis leading to infertility [196] indicating that chromatin repackaging 
is an essential process that must be undertaken for viable sperm production [197]. 
Here, we set out interrogate the role of SOX3 in spermatogenesis by profiling SOX3 
binding sites in mouse postnatal testes at genome-wide scale using ChIP-Seq. We 
identified 778 putative SOXB1 binding regions, including sites close to Ngn3, H3f4, 
Hist1h2aa and Hist1h2ab, genes known to play important roles regulating sperm 
development. Further, we show SOX3 and PLZF binding near a large number of 
histone genes, suggesting they share a common regulatory role in histone gene 




5.3.1 CHARACTERISTICS OF SOX3 BOUND REGIONS IN P7 TESTES 
To identify physiologically-relevant SOX3 target sites in the postnatal mouse testes, 
three replicate ChIP experiments were performed on independent P7 testes using 
a previously validated SOX3 specific antibody [188]. Sox3 is expressed in 
spermatogonial progenitor cells at P7, although no testis phenotype is evident in 
null mice at this stage [108]. Independent replicate datasets were overlain and 
overlapping regions identified from the peak sequences. Across the three 
experiments, 2912, 2598 and 2734 peaks were identified. Only 241 regions were 
present in all samples, whereas 778 regions were present in at least 2 of 3 samples. 
This group of 778 was used for further analysis.  
To determine the genomic context of SOX3-bound regions, HOMER ChIP-Seq 
analysis was performed (Figure 1A). This revealed that 50% of the sites were 
intergenic (388/778), 31% are intronic (243/778), 11% are in the promoter region 
(86/778), 4% are within exons (29/778), 2% are at transcriptional start and stop sites 
(18/778) and 2% are within 3’ or 5’ UTRs (14/778). 
ChIP peaks often represent regulatory regions that act upon their nearest 
neighboring gene, either proximal or distal to each peak location. GREAT (Genomic 
Regions Enrichment of Annotations Tool) uses ChIP-Seq-identified peaks and 
genomic annotations to predict statistically enriched cis-regulatory regions and 
gene ontology (GO) functions [198]. The top five terms associated with SOX3 ChIP 
peaks were “negative regulation of megakaryocyte differentiation”, “nucleosome 
assembly”, “nucleosome organization”, “chromatin assembly” and “chromatin 
assembly or disassembly” (Figure 1B). There is a highly significant enrichment for 
functional association with nucleosomes and chromatin environment 
(Supplementary Table 1). Interestingly, the majority of the peaks are located close 
to various histone, and histone modifying genes such as Brd2, Setd2 and H2afx.  
We calculated the average phastCons score of all SOX3 bound regions, based on 
the conservation between 30 placental mammals (< 0.1 low conservation, 0.1-0.5 
moderate conservation, and >0.5 high conservation) (Figure 1C). The majority of 
the sequences were poorly conserved (65%), with 23% moderately conserved and 
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12% highly conserved. Assessing the genomic location of the 92 highly conserved 
SOX3 peaks indicated that the largest proportion of peaks were either within a 








Figure 1. Overview of SOX3 ChIP-Seq biding sites in mouse P7 Testis. (A) The 
genomic context of all SOX3 peaks in mouse P7 testis. Transcriptional start and stop 
sites (TTS) and both 5’ and 3’ untranslated regions (UTR). (B) Enriched Gene 
Ontology terms identified by GREAT based on the nearest neighbouring gene to 
each SOX3 peak. (C) PhastCons score distribution of all 778 testes peaks. Most 
peaks are located in regions of low evolutionary conservation. The 92 highly 
conserved peaks were assessed for their genomic location, with the largest 




5.3.2 MOTIF DISCOVERY IN CHIP-SEQ PEAKS 
Previously, we identified SOX3 binding motifs in NPCs, as well as a core SOXB1 motif, 
which highlighted the central ACAA nucleotides as critical for SOXB1 DNA binding 
[188]. To compare SOX3 binding in NPCs and spermatogonial stem/progenitors, we 
performed de novo motif analysis on the SOX3 testes ChIP peak sequences.  We 
identified a SOX3 motif that is shorter than the one identified in NPCs (Figure 2A) in 
421/778 (53%) of all peaks (E-value of 8.6e-457 (Figure 2B). The de novo testes 
motif is located close to the center of most ChIP-seq peaks (Figure 2C). 
Comparison of the de novo SOX3 motif with the SOX3 motif identified in NPCs 
reveals a number of differences: Position 2 favours an A in testes and a G in NPCs, 
position 4 favours a C in testes and either a G or C in NPCs, position 7 accepts an A 
in both cell types as well as a T in the testes. Positions 9, 10 and 11 are not present 
in the testes motif. The de novo SOX3 motif identified in testes is very similar to the 
SOXB1 motif identified in McAninch and Thomas 2014, with the addition of 2 A 






Figure 2. Motif identification in SOX3 bound regions. (A) De novo identification of 
SOX3 binding motifs within the peak sequences using MEME (E-value 5.6e-11). 
Comparison of the de novo SOX3 motif discovered in testes ChIP-Seq peaks with 
the SOX3 and SOXB1 motifs discovered in NPC (McAninch 2014). (B) 421 of the 778 
peaks contain the de novo SOX3 motif identified in (A). (C) Positional analysis of the 
de novo SOX3 motif in all 778 peaks showing that the motif is highly central.  
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5.3.3 IDENTIFICATION OF PUTATIVE SOX3 PARTNER PROTEINS  
SOX proteins have been shown to co-regulate expression of target genes with 
varying partner factors, dependent upon the tissue context [53,102,104,105,164]. We 
used motif enrichment analyses to identify the most significantly enriched motifs 
present within the 778 SOX3 peak sequences. Using AME (Analysis of motif 
enrichment) [199] and the HOCOMOCOv11 Mouse motif database [200], we 
identified more than 20 significantly enriched motifs, aside from SOX motifs. The 
top 6 most significantly enriched binding sites included motifs for SOX-POU, DMRT1, 
TEAD2, STAT1, GFI1B and NRF5A2, with Р values less than 2e-10 (Table 1). Aside from 
the SOX-POU motif, none of these proteins have been shown to be SOX-protein 
partners. Consistent with this, none of the motifs, excluding SOX-POU, were in close 
proximity to the SOX3 DNA binding motif, suggesting coregulation but not direct 
interaction. 
5.3.4 IDENTIFYING DIRECT SOX3 TARGET GENES THROUGH CHIP-SEQ AND MICROARRAY 
ANALYSES 
A microarray study comparing postnatal mouse testes of wild type and Sox3 null 
mice was performed previously to identify differences in gene expression caused 
by the loss of Sox3 [120]. From this data, 18 genes were found to be significantly 
dysregulated in response to the lack of SOX3. To identify putative SOX3 direct 
target genes, we compared these genes to the ChIP-Seq data. Only 1 peak 
sequence had a nearest neighbour that belonged to the 18 significantly altered 
genes - neurogenin3 (Neurog3, also known as Ngn3). The microarray showed Ngn3 
was downregulated 2.9 fold, compared to wild type. The peak sequence for Ngn3 
is approximately 3kb upstream of the TSS, and is within a larger region of 
conservation, potentially a large regulatory region (Figure 3). We have previously 
identified a SOX3 binding peak directly upstream of the Ngn3 TSS in NPCs [188]. 
However, the peak identified in the testes is further upstream indicating SOX3 may 
regulate Ngn3 expression through different regulatory regions depending on cell 




Table 1. Summary of the top 6 most significant motifs found within SOX3 bound 


















































































Figure 3. Ngn3 is a direct target of SOX3 in testes. Comparison of the ChIP and 
microarray datasets identified Ngn3 as a direct target of SOX3 in P7 mouse testes. 
UCSC browser view of Ngn3 and the promoter region, overlayed with the testes 
and NPC ChIP peaks. Both peaks contained the same SOX3 binding motif, and both 
exist within highly conserved regions of the genome. 
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5.3.5 SOX3 BOUND REGIONS PRESENT IN TESTES AND NPCS 
Our previous ChIP-Seq analysis of mouse NPCs (using the same SOX3 antibody)  
identified 8064 regions bound by SOX3 [188]. To further understand the context-
specific role of SOX3 in stem cells, we compared the ChIP targets from testes and 
NPCs. A total of 218 regions were bound by SOX3 in both tissues (Figure 4), 
suggesting some overlap of SOX3 function exists between these two distinct types 
of stem/progenitor cells. We used GREAT to identify enriched GO terms for three 
separate groups; peaks common to both data sets, NPCs only, P7 testes only.  
Significant enrichment for terms involving “chromatin modification”, “nucleosome 
and chromatin assembly”, as well as the “negative regulation of megakaryocyte 
differentiation” were identified for the 218 common peaks (Figure 4). Peaks found 
only in NPCs were associated with “maintenance of cell numbers”, “epigenetic gene 
regulation”, “retinoic acid signaling”, and “gliogenesis”. The 570 peaks unique to P7 
testes showed no significant enrichment for any GO terms (Figure 4). These data 
suggest SOX3 may have a greater number of unique regulatory roles in NPCs, 





Figure 4. Comparison of NPC and P7 testes SOX3 ChIP-seq peaks. (A) 
Comparison of the NPC and testes datasets show that 218 peaks are common to 
both tissues. GO enrichment analysis of the different groups of peaks indicates a 




5.3.6 SOX3, PLZF AND SALL4 TRANSCRIPTIONAL MECHANISMS IN SSCS 
During spermatogenesis, SOX3 expression overlaps extensively with PLZF and 
SALL4, two zinc finger TFs expressed within a subset of undifferentiated SSCs [201] 
(D McAninch, JA Mäkelä, HM La, JN Hughes, R Lovell-Badge, RM Hobbs, & PQ 
Thomas, manuscript under review). Loss of Plzf results in the depletion of SSCs and 
spermatogenic arrest [154,155] while loss of Sall4 results in a failure of SSC 
maintenance and differentiation [202]. Given the loss of any of these three TFs 
results in a spermatogenic defect, we wanted to identify if they share common 
regulatory targets. 
Comparison of three ChIP-seq datasets, SOX3 from testes, and PLZF and SALL4 
from isolated THY1+ SSCs [201], identified 52 common peaks between SOX3 and 
PLZF and 51 between SOX3 and SALL4 (Supplementary Figure 1). All three factors 
are located at 20 common genomic regions. GREAT analysis identified one 
enriched GO term for the nearest genes associated with the 20 common peaks, 
“Chromatin organisation” (Р = 2.39e-7). Interestingly, 80% of the binding sites 
associated with the GO term we found within 5kb of a promoter (Supplementary 
Figure 1).  
5.3.7 COMMON TARGETS OF SOX3 AND PLZF IN TESTES AND SOX3 IN NPCS 
Due to similar GO terms being identified in both SOX3 testes/NPC and SOX3/PLZF 
comparisons, we further compared SOX3 in testes, SOX3 in NPCs and PLZF from 
SSCs. While the majority of SOX3 and PLZF bound regions are unique to each TF, 
there is a core group of 34 genomic regions present in all three ChIP-seq datasets 
(Figure 5A). GREAT analysis identified a number of significantly enriched terms, of 
which “chromatin assembly” was the most significantly enriched (Figure 5 B). Peaks 
associated with the GO term “chromatin assembly” were almost exclusively located 
within 5kb of the transcription start site (Figure 5 C), most were within 500bp.  
Due to the large number of histone genes with nearby SOX/PLZF binding regions 
we examined the 3 mouse histone clusters, Hist1, Hist2 and Hist3 for ChIP peaks 
from all three datasets (Figure 5 D). Histone genes in Hist1 are almost all bound by 
both SOX3 (testes and NPCs) and PLZF, with a few exceptions, e.g. Hist1h4b is only 
bound by SOX3 and not PLZF. The Hist2 cluster is exclusively bound by SOX3 in 
both testes and NPCs, while the SOX3 binding site near Hist2h4 is only found in 
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NPCs. Hist3 is almost exclusively bound by PLZF, with the exception of H3f4 that is 
also bound by SOX3 in the testes but not NPCs. In addition to the histone clusters, 
there are ChIP peaks located at two additional testes specific histone genes, 
Hist1h2aa and Hist1h2ab (Figure 5 E). 
These data suggest common regulatory mechanisms exist between SOX3 and 
PLZF with a focus on chromatin regulation. This common mode of action by SOX3 





Figure 5. Comparison of NPC and P7 testes SOX3 ChIP-seq peaks with SSC PLZF 
ChIP-seq peaks. (A) Comparison of two SOX3 and one PLZF ChIP-seq datasets 
show 34 common peaks between all 3 datasets. SOX3 shares 218 peaks between 
two different tissue types. (B) GO enrichment analysis of the nearest genes to the 
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34 common peaks identified in (A). (C) Proximity of the peaks to the TSS of the 
nearest gene enriched in the “chromatin assembly” GO term. (D) UCSC genome 
browser view of the three ChIP-seq datasets looking at the Hist1, Hist2 and Hist3 





SOX3 is expressed within the undifferentiated pool of spermatogonial 
stem/progenitor cells in postnatal testes, and whilst it is known that loss of this TF 
leads to spermatogenesis defects and sterility, its transcriptional targets in this 
context were previously unknown [107,108]. Using ChIP-Seq analysis we have shown 
that SOX3 binds to 778 genomic regions within postnatal testes, and through 
integration with other data have identified putative SOX3 bound regulatory regions 
that may be important for the initiation and progression of spermatogenesis, as 
well as the regulation of histone gene expression. Peaks identified from testes SOX3 
ChIP-seq were mostly found within intergenic and intronic regions, consistent with 
other SOX3 and SOXB1 TF ChIP-seq analyses [188,203,204], suggesting a regulatory 
role via enhancer binding. Conservation analysis via PhastCons scoring showed 
that 12% of bound regions had high conservation, indicative of their importance 
within the mammalian genome.  
While the majority of the peaks we identified contained a SOX motif, 367 out of the 
778 peaks did not. There is often flexibility in TF binding motifs, which can be 
influenced by partner factor binding, and may reduce the ability to confidently 
identify shorter motifs [53,205]. Alternatively, these may be representative of DNA 
looping events and incorporating partner protein binding sites. Chromosome 
conformation capture experiments would be required to tease out these fragment 
identities and confirm that they were physically connected at the time of fixation 
and not just background DNA pulldown [206].  
De novo motif discovery identified a similar SOX3 binding motif to those we 
previously identified in NPCs. This motif was featured within a majority of the 778 
peaks, and was significantly associated with the center of the ChIP peaks 
supporting bona fide SOX3:DNA interaction [207]. The motif we identified in the 
testis is shorter and has a number of differences when compared to the motifs 
identified in NPCs. This may be due in part to SOX3 binding to DNA with different 
partner factors, a common mechanism of SOX TFs [53]. Our comparison here 
shows that SOX3 binds consistently to a core motif where the central ACAA 
nucleotides appear to be the most critical.  
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Dozens of DNA binding motifs were enriched with the peaks with high significance, 
the top 6 presented in Table 1. Most motifs were too distantly spaced from the SOX3 
motif for direct protein:protein interaction except for the SOX-POU motif, which was 
the most significantly enriched. SOX3 has been shown to bind co-operatively with 
OCT4/POU proteins in the nervous system [101,106,208], and this was further 
supported by a SOXB1 ChIP-Seq experiment in mouse NPCs [188]. OCT4 is known 
to be expressed within the gonocytes and spermatogonial stem cells along with 
SOX3, and is required for the self-renewal of the SSC population [209,210]. Thus, it 
seems likely that OCT4 is a partner protein for SOX3 in the mouse testes.  
While almost all cells package DNA using histones, mature sperm package DNA 
using protamines. During the progression of spermatogonia through 
spermatogenesis there is complete reorganization of the chromatin structure 
within the nucleus [211]. Initially, standard histones are replaced with testes-specific 
histone variants. As spermatogonia undergo spermiogenesis these variants are 
replaced with transition proteins before finally being replaced by protamines as the 
sperm mature. Here we found SOX3 and PLZF bind to three different testes-specific 
histone variants H3f4, Hist1h2aa and Hist1h2ba. H3T (encoded by H3f4) has been 
shown to be essential for entry into spermatogenesis [197]. The H3T histone variant 
is incorporated into the genome prior to spermatogenesis, displacing the canonical 
H3 variant. Similar to Sox3 knockout mouse models, loss of H3f4 leads to reduced 
testes weight and a loss of germ cells [197]. Further analysis of SOX3 binding at this 
region is warranted, and may reveal a link between the loss of SOX3 leading to 
infertility through reduced or lack of H3T replacement of canonical H3 within the 
spermatogonial stem cells. 
We identified a single ChIP-Seq peak, common to three datasets (PLZF in SSCs, and 
SOX3 in NPCS and testes) at the Hist1h2aa and Hist1h2ba loci, encoding TH2A and 
TH2B, respectively. These testis-specific histone variants replace the canonical core 
histone proteins H2A and H2B within the early spermatocytes and are encoded by 
genes that have a common promoter [212,213]. The replacement of H2B with TH2B 
is not essential for spermatogenesis [213]. Hist1h2ba knockout mice show no 
obvious spermatogenic defects, H2B expression is maintained until the end of 
spermatogenesis, rather than shutting down [213]. However, loss of both Hist1h2ba 
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and Hist1h2aa leads to defects in spermatogenesis and infertile males [214]. Neither 
Hist1h2aa nor Hist1h2ba have been identified as being differentially expressed 
either Sox3 null mouse testes or Plzf null spermatogonia when compared to their 
respective controls [120,155]. The lack of any significant differences in expression 
of either of these genes in both knockout models suggest that SOX3 and PLZF (or 
other TFs) may be able to compensate for the loss of one another. qPCR analysis 
of type A spermatogonia from Sox3 or Plzf null testes could help determine if there 
are subtle differences in gene expression, not detected by microarray. Additionally, 
SSC specific double knockout mouse model of Sox3 and Plzf would help confirm 
not only if they regulate Hist1h2aa and Hist1h2ba, but also demonstrate the 
existence of compensatory mechanisms. 
A number of genomic regulatory regions and promoters were observed to be 
bound by multiple TFs, including SOX3, PLZF, and or SALL4. Multiple TF binding sites 
within a single element provide opportunities not just for synergistic amplification 
of transcription, or increased control, but also provide an additional layer of 
redundancy [97,99,100]. Genes like His1h2aa and Hist1h2ba feature SOX3 and PLZF 
binding sites at their shared promoter, however no change in gene expression is 
observed in single knockout mouse models of either Sox3 or Plzf [120,154,155,201]. 
Conversely, genes such as Ngn3, bound uniquely by SOX3, or Fos, bound uniquely 
by PLZF, do result in reduced gene expression in their respective knock out mouse 
models [120,154,155,201]. These direct, uniquely bound targets appear likely to play 
a role in generating the phenotypes observed in the knockout mouse models 
[92,107,109,155,201,202].  
Overlapping ChIP data for PLZF in SSCs and SOX3 in testes and NPCs indicate they 
share 34 binding sites. These sites include the promoters of 24 histone genes across 
three different sample types. The GO term “Negative regulation of 
megakaryocytes” (a term consisting mostly of histone genes) is identified as 
significant in each individual dataset, and also enriched for the peaks common to 
all three. Binding of all three TFs is observed within the Hist1 cluster, whereas the 
Hist2 and Hist3 clusters appear to be bound exclusively by either SOX3 or PLZF 
respectively. Most histones within the 3 clusters are replication dependent histones 
[215], implicating both SOX3 and PLZF in cell replication mechanisms, however the 
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reason only SOX3 binds Hist2 and only PLZF is found at Hist3 remains unclear. ChIP-
Seq datasets are unlikely to represent a complete list of TF binding sites, due to 
both experimental and analytical challenges. We included peaks found in a 
minimum of 2 out of 3 datasets in order to capture as many regions as possible. 
Alternatively, ChIP-seq performed on SOX3 and PLZF from the same source 
material, or a SOX3/PLZF re-ChIP experiment would help strengthen this 
comparison. Previously, SOXB1 TFs have been linked with the posttranslational 
modification of histones their pioneer factor activity [55]. However, no studies to 
date have implicated any SOXB1 TF in the regulation of histone gene expression. 
These data suggest that one of the core functions of SOX3 (and PLZF) is to regulate 
histone gene expression. 
In summary, we used ChIP-Seq to identify 778 SOX3 bound regions of the genome 
in the postnatal mouse testes, including a number of putative enhancers implicated 
in spermatogenesis. Additionally, we have described a number of common genes 
and promoters linking SOX3 and PLZF to histone gene regulation in postnatal 
mouse testes/SSCs. These data provide a platform for further functional analysis 
to investigate the function of SOX3 within the testes. This work has provided the first 
evidence of a core, tissue independent role for SOX3 in regulation of histone genes.  
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5.5 MATERIALS AND METHODS 
5.5.1 ETHICS STATEMENT 
Animal experiments were subject to approval by the Animal Ethics Committees of 
the University of Adelaide. All studies were conducted within the principles of animal 
replacement and reduction and experimental refinement. Animals were monitored 
daily for evidence of illness and, if distressed, were culled immediately by cervical 
dislocation by an experienced investigator/animal technician. All the experiments 
were performed in accordance with the approved guidelines and regulations. 
5.5.2 CHROMATIN IMMUNOPRECIPITATION 
Testes from postnatal day 7 wild type mice (129/SvJ) were collected transferred to 
ice cold 1xPBS containing protease inhibitors. Testes were mechanically dissociated 
before crosslinking in 1% freshly prepared formaldehyde for 8 minutes at room 
temperature. Fixed testes tissue was then lysed and sonicated (Bioruptor, 
Diagenode) for 15 minutes in 30 second pulses on ice. SOX3 bound chromatin was 
immunoprecipitated by a goat polyclonal antibody raised against human SOX3 
(R&D systems, AF2569), previously used for ChIP-Seq [188] and shown to be SOX3 
specific [93]. DNA was recovered by reversing crosslinks, and purified by PCR 
product purification kit (QIAGEN). Three independent DNA libraries were produced 
from testis from three independent mice with the Illumina TrueSeq library kit as per 
manufacturer's instructions, and libraries were sequenced using the Illumina HiSeq, 
producing 50 bp single end reads. A control sample (without SOX3 antibody) was 
run as input for background control.  
5.5.3 PEAK CALLING 
As published in McAninch & Thomas 2014, Bowtie [216]  was used to align reads to 
the mouse genome (mm9). Peaks were called for each biological replicate using 
MACS [217], with bandwidth of 300, a model fold of 10–30, using input sample as 
background control, and a p-value threshold of 1e-5. Only peaks present in at least 
2 of 3 biological replicates were retained. 
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5.5.4 GENE ONTOLOGY 
Gene ontology was performed using the GREAT webtool [198] on the mouse mm9 
genome. The default settings of ‘basal plus’ were used to define the genomic 
regions and the whole genome was used for background regions.  
5.5.5 DE NOVO MOTIF ANALYSIS  
MEME-ChIP was used to identify DNA enriched motifs from SOX3 bound peaks, 
searching for any number of repetitions of non-overlapping motifs. Default 
parameters were used and the HOCOMOCO v11 database of known mouse and 
human motifs [200]. WebLogo was used to visualise de novo motifs generated by 
MEME-ChIP [218]. FIMO (Find Individual Motif Occurrences), part of MEME-Suite, 
was used to confirm peak regions containing the motifs identified previously 
[219,220].   
5.5.6 CONSERVATION ANALYSIS 
PhastCons scores were generated for each peak sequence [221]. These were then 
ranked, and sorted into high, moderate and low conservation based on their mean 
score [221].  
5.5.7 PUBLISHED CHIP-SEQ AND MICROARRAY DATA 
Raw and processed data were submitted to NIH Gene Expression Omnibus (GEO) 
and Sequence Read Archive (SRA) databases under accession number GSE146706. 
SOX3 ChIP-Seq data from NPCs was obtained from NCBI GEO database GSE57186 
[188]. Microarray data of Sox3 null testes obtained from NCBI GSE96805 [120]. PLZF 
and SALL4 ChIP-seq was obtained from GSE73390 [201] and PLZF microarray 
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Figure S1. Comparison of P7 testes SOX3 ChIP-seq with PLZF and SALL4 SSC 
ChIP-seq peaks. Comparison of testes and SSC ChIP-seq datasets for SOX3, PLZF 
and SALL4 show 20 peaks common to all three datasets. GO analysis of the genes 
neighbouring the 20 common peaks identified a single enriched GO term, 
“chromatin organisation”. Almost all histone neighbouring peaks do not overlap 
with SALL4. GO enrichment identified “chromatin assembly” as the only enriched 
term for the 32 peaks common to SOX3 and PLZF datasets. The peaks associated 
with the two GO terms identified were almost exclusively found within 5kb of a 
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6.1 SOX3’S GENOMIC FINGERPRINT IN NPCS AND SSCS 
 
6.1.1 EVOLUTIONARY CONSERVATION OF SOX3 BOUND REGULATORY REGIONS  
SOX3’s genome wide binding sites have now been mapped in two tissues (NPCs 
and testes) in three independent ChIP-seq experiments, Bergsland et al. 2011, 
McAninch and Thomas 2014 (Publication I), and Manuscript II. SOX3 shows an 
overwhelming propensity for binding intergenic and intronic regulatory regions in 
preference over binding directly at proximal promoters. Publication I, highlights that 
more than 50% of these non-promoter binding sites are located in regions of high 
evolutionary conservation in NPC, while Manuscript II shows only 12% are highly 
conserved in testes. We highlighted the probability that many of these sites are 
highly conserved neural enhancers in NPCs. This high level of conservation 
indicates these regions are under significant selective pressure to remain 
unchanged [223]. Conversely, the low degree of conservation seen in the testes 
peaks suggests that these regions are subject to different selective pressures.  
SSCs undergoing spermatogenesis undergo a large number of cell divisions before 
they reach mature sperm – and each division provides the opportunity to introduce 
alterations to the genome. These changes can increase or decrease the genetic 
fitness of resultant sperm, with the ultimate goal being egg fertilization. As a 
consequence, mutations that increase sperm fitness are more likely to be passed 
to the next generation. As sexual reproduction selects for the “fittest” sperm, 
mutations that lead to increased sperm numbers, changes in morphology and 
organisation within the testes are often favoured. These mutations can be present 
within protein coding regions to change gene function, or within regulatory regions 
(promoters and enhancers) to modify gene expression levels or domains of 
expression. In general, reproductive genes, such as those required for 
spermatogenesis, evolve at a much faster rate than non-reproductive genes [224-
226]. It is possible that the same is true for their regulatory regions, which may 




6.1.2 CHARACTERISING PUTATIVE SOX3 BOUND REGULATORY REGIONS 
Between the three SOX3 ChIP-seq datasets, there are more than 15,000 SOX3 
binding regions genome wide. ChIP-seq data only provides a snapshot of 
information for where TFs were located at the time of fixation. No further 
information is provided pertaining to activity at each location, ie. activating or 
repressing gene expression, regulating epigenetic marks, or scanning DNA for an 
appropriate binding site. Traditional methods for identifying areas of expression 
controlled by enhancers have involved making transgenic mice, with a LacZ 
reporter gene under the control of a genomic region of interest. Alternatively, 
enhancer trap reporter lines have been used as a non-targeted approach to 
enhancer discovery [227]. While these approaches provide some information on 
the control of gene control, moving enhancers from their normal genomic locus 
removes any context-dependant regulation. 
Given the recent emergence of CRISPR/Cas9 genome editing technologies, it is now 
possible to take the identification and classification of TF binding sites further than 
before. Simple genomic modifications, such as TF binding site mutations, can be 
created to assess the role of virtually any TF binding site on endogenous gene 
expression. Binding site mutations within cell lines and/or mice, can be created and 
examined for effects on gene expression, TF binding via ChIP-PCR, and phenotype 
characterisation, providing functional information for TF binding sites. 
Investigating the function of the SOXB1 bound neural enhancers, identified in 
Publication I, would be of significant interest. Binding site and enhancer deletion 
mutants could provide precise information as to the importance of individual 
binding sites and enhancers for gene expression. Analysis of embryos, or adult mice 
for gene expression by real time PCR, whole mount in situ hybridisation, and 
immunohistochemistry could give spatial information about regions of expression 
controlled by a single TF binding site or entire enhancer. With the rise of whole 
genome sequencing, disease-causing mutations within enhancers are an emerging 
area [228-230]. Analysing SOXB1 bound enhancers may help to tease apart the 
precise transcriptional mechanisms by which SOX3 acts, ultimately linking 
enhancers to regions of gene expression. Indeed, research performed by others in 
the Thomas lab has shown that deletion of the SOX-bound Nes enhancer results in 
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a significant reduction in Nestin expression in the developing CNS (Thomson, E.P., 
PhD Thesis, 2019). 
 
6.1.3 INTERACTIONS WITH OTHER PROTEINS 
The SOX/POU interaction has been the focus of many previous studies, including 
x-ray crystallography to identify how these proteins physically interact [57]. It has 
been demonstrated in vitro that co-operative interactions between SOX and POU 
proteins lead to greater responses than either TF alone [53,105,106,231].  The 
binding strength of SOX proteins is quite low, with a KD between 10-8-10-9M, while 
strong DNA binding domains are around 10-11M [53]. With such low binding affinities 
it is unlikely that SOX TFs are able to activate enhancers alone. The SOX/POU 
binding motif was identified in both NPCs and testes ChIP-seq peaks. Interestingly, 
in both cell types’ nucleotides closest to the centre of the SOX/POU motif were not 
as conserved as those on the outside of the motif, when compared to the SOX3 
only DNA binding motif. This is consistent with the crystal structure of the SOX/POU 
DNA interaction that indicates the outer nucleotides of the SOX motif are the only 
nucleotides that contact the HMG domain [57]. It is likely that cooperative binding 
between SOX3 and POU TFs alters how SOX3 binds DNA, likely through changing 
the physical interaction between the HMG domain and DNA. To date, there is no 
crystal structure of the SOX HMG domain without a binding partner, likely due to 
the weak DNA binding properties of the HMG domain. Developing a crystal 
structure of the SOX HMG domain with a different binding partner might help 
identify whether SOXB1 proteins have altered DNA binding properties depending 
on their binding partner.  
Aside from the SOX/POU motif, both of our ChIP-seq datasets (Publication I, 
Manuscript II) failed to identify any significant enrichment for nearby partner factor 
binding sites. This may suggest that SOX3 doesn’t have much/any preference for 
cofactors, and will co-operatively influence gene expression with any available 
partner proteins. During this PhD a yeast 2 hybrid screen was performed in an 
attempt to identify potential co-factors for SOX3. The N-terminal region of SOX3 
and its HMG domain was used as the bait, (as the activator domain interferes with 
the assay), and the library was generated from 11 day mouse embryos (Clontech). 
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Unfortunately, none of the potential interacting partners identified by this assay 
were able to be validated. We also performed a co-immunoprecipitation assay, 
where SOX3 was pulled down out of cell lysates using an antibody for SOX3. The 
resulting proteins were separated by polyacrylamide gel electrophoresis, and 
potential interacting partners were identified by mass spectrometry. Histones were 
the only proteins identified, and were likely identified as an experimental artefact 
as SOX3 is bound to DNA a majority of the time. These data suggest that SOX3 may 
be a weak protein interactor, as it is with DNA.  
SOX3 partner factors remain elusive, and pulldown/non-endogenous interactions 
may be too harsh to produce useful data. Proximity based labelling may be a useful 
technique to identify these interactions, as it doesn’t require the interactions to 
remain in place during the harsher conditions of pull down experiments. BioID is a 
proximity based labelling technique, successfully performed with TFs including 
SOX2 [232], that uses a modified Biotin Ligase attached to a protein of interest. 
Proteins in close proximity to the bait are then modified with biotin on exposed 
lysine residues. Biotinylated proteins can then be captured using a streptavidin 
matrix and identified by liquid chromatography-tandem mass spectrometry [233]. 
This method would allow for the identification of neighbouring proteins, even if 
there is no strong binding affinity between them.  
Due to the extensive number of ChIP-seq datasets in existence, there are numerous 
databases of known DNA binding motifs for a number of different TFs and DNA 
binding proteins. We scanned our ChIP-seq peaks for enriched binding sites that 
were in close proximity to the SOX3 motif, with only the SOX-POU motif identified 
conclusively. These methods look for potential binding partners in the same 
location, however we know that DNA looping can play a large role in enhancer 
based gene expression control [234,235]. Thus, binding partners and cofactors may 
be located at a distant site rather than in close proximity to SOX3.  
Both of our ChIP-seq data sets contained peaks that featured no identifiable SOX3 
or SOX motif (Publication I, Manuscript II). This is common for ChIP-seq datasets 
and generally arise from either; DNA linked by protein:protein interactions, and 
therefore indirectly bound by the target TF or alternatively, from non-specific 
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antibody pulldown of either non-specific proteins or fragments of DNA  [236,237]. 
Recently, it has been proposed that some biological artefacts may arise due to 
protein complexes, such as Cohesin and Polycomb, linking otherwise unrelated 
regions of genomic DNA and showing up as enriched peaks in ChIP-seq datasets 
[238]. Ultimately DNA pulled down due to protein:protein interactions (such as SOX3 
and a binding partner) would be of most interest. Unfortunately, due to the 
complexity of these interactions and the simplicity of the ChIP-seq datasets, these 
interactions cannot be identified without further experimentation, such as 




6.1.4 LOSS OF SOX3 HAS A MINIMAL EFFECT ON GENE EXPRESSION IN TWO 
DIFFERENT CELL TYPES 
Knowing the genome wide binding profile of a TF is critical, yet insufficient, when it 
comes to understanding the function of TFs. Understanding what happens after a 
TF binds to DNA is just as important. We performed genome wide transcriptional 
profiling of Sox3 null NPCs [189] and Sox3 null testes by microarray [120]. We set 
out to characterise how the transcriptional profile of NPCs and testes change in the 
absence of SOX3, as discussed in Rogers et al. 2013 and Adikusuma et al. 2017 
[120,189]. 19 genes were identified as being significantly differentially expressed in 
Sox3 null NPCs, and 17 in Sox3 null testes when compared to their WT controls. It 
was surprising to see so few changes in gene expression, given the large number 
of SOX3 binding sites identified by ChIP-seq. Originally it was proposed that the 
small number of changes to gene expression in NPCs might be due to functional 
redundancy between the highly similar SOXB1 proteins. However a similar number 
of differentially expressed genes were identified in the testes, where SOX1/2 are not 
present and therefore cannot act in a functionally redundant manner. Perhaps 
functional redundancy extends beyond SoxB1 proteins and highly important gene 
expression is protected by more than one TF/family. Although it is important to 
note that despite the few gene expression changes in the testes, there are 
observable phenotypes in Sox3 null mice. 
Although there were fewer differentially expressed genes than expected, one of 
particular interest in NPC was Dbx1, which was found to be decreased in Sox3 null 
NPCs by microarray analysis [189]. This reduction in Dbx1 was similarly reflected at 
the protein level, with fewer DBX1+ cells present in Sox3 null NPC populations. This 
reduction in both RNA and protein was also observed in vivo in 9.5 dpc mouse 
embryos. We identified numerous SOX3 binding sites located near Dbx1, two within 
the second intron and three further upstream, indicating it is likely Dbx1 is a direct 
target of SOX3. We know that SOX3 binds to these elements in vivo, and we know 
Dbx1 expression is reduced in the absence of SOX3, however more information is 
required to confirm direct regulation. As discussed above, CRISPR/Cas9 genome 
editing tools can be used to create SOX3 binding site mutations in NPCs to confirm 
this direct regulation. Either the entire binding peak can be deleted, or the SOX 
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binding site mutated in ESCs, and NPCs generated from these cells assessed for 
Dbx1 expression by qPCR. Further, the CRISPR/Cas9 system could be used in mice 
to generate the same mutations and confirm their importance in vivo in 9.5 dpc 
mouse embryos. Additionally, ChIP-PCR performed on these same embryos could 




6.1.5 NAVIGATING THE EPIGENETIC LANDSCAPE AROUND SOX3 
A major step towards understanding SOX3’s function would be to survey the 
chromatin landscape in NPCs or SSCs with and without the presence of SOX3. These 
methods will help distinguish which binding sites are important now and which sites 
will be important as the cells differentiate. The techniques below are best 
performed on populations of single cell types to help reduce noise and classify the 
landscape specifically in SOX3 expressing cells. Cultured NPCs should be suitable, 
however isolation of SSCs would aid in simplifying the datasets. Protocols exist to 
isolate SSCs via magnetic cell sorting [239].  
Histones make up the protein core of nucleosomes; 4 different histones in duplicate 
make up the octamer core, which is wrapped in DNA to form chromatin. These 
nucleosomes help compact DNA, allowing it to fit within the nucleus of a cell. 
Posttranslational modifications to the tails of these histones, a short amino acid 
chain that extends out from the nucleosome, are associated with different states of 
chromatin condensation, accessibility and function. Some of the better 
characterised histone marks include; H3K9me3, trimethylation at lysine 9 of histone 
3, found at condensed chromatin [240,241]; H3K4me3, trimethylation at lysine 4 of 
histone 3, found at active gene promoters [242,243].   
The histone code at enhancers can distinguish between 3 different states; active, 
primed and poised [244-247]. An active enhancer is one that is found in open 
chromatin, able to bind TFs and aid in the recruitment of Pol initiating strong gene 
transcription, these enhancers are enriched for H3K27ac and H3K4me1. Primed 
enhancers are enriched for H3K4me1 and not H3K27ac, and will drive basal 
expression of their target genes. Poised enhancers are enriched for H3K4me1 
(activator modification) and H3K27me3 (repressive modification) that hold the 
enhancer in an inactive state. Upon differentiation, the trimethyl group is removed 
from H3K27 and is acetylated to become H3K27ac, inducing strong expression of 
its target gene. Poised enhancers, which are a relatively new concept, are only 
required after the cell differentiates, implying that the use of a poised enhancer has 
been predetermined. Poised enhancers allow for the rapid expression of genes 
upon differentiation.  
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ATAC-Seq (Assay for Transposase-Accessible Chromatin) is a relatively new 
method developed to generate a global landscape of chromatin compaction [248]. 
It is a sensitive alternative to DNase- and MNase-Seq, providing both chromatin 
accessibility and nucleosome position information and can be performed with 
limited starting material. The method uses a hyperactive mutant of the transposase 
Tn5, which cuts DNA and ligates in adapters in regions of accessible chromatin. 
High numbers of sequencing reads in a single area indicate the chromatin is more 
accessible to transposase and therefore in a more open chromatin state. Reads of 
less that 150bp indicate that region is protected by nucleosomes, providing 
information on the nucleosomal landscape. Given SOX3’s potential pioneer activity 
combining ChIP-seq and ATAC-seq from the same cell types will help to clarify 
which binding sites are normal TF sites and those that are pioneer sites (if any).  
Overlapping regions of closed chromatin, i.e. minimal to no sequencing reads and 
ChIP-seq peaks would suggest pioneer activity.  
Alternatively, chromosome conformation capture coupled with high throughput 
sequencing (Hi-C) would provide experimental evidence towards which regions are 
directly bound by SOX3 and those connected thought cooperative interactions 
[249,250]. Hi-C works by crosslinking protein and DNA, as you would in ChIP, 
followed by restriction digest of the DNA providing compatible DNA ends. The DNA 
is then ligated while still attached to the TF, this is performed at low DNA 
concentrations to minimise ligations between fragments bound to different TF 
molecules. Crosslinks are reversed, and DNA is sequenced. Mapping of DNA 
sequences provides information regarding which regions of the genome are linked. 
Together these data would provide more conclusive evidence towards which 
enhancers are bound by SOX3 and which genes these enhancers are targeting.  
Combining ChIP-Seq, ATAC-Seq, Hi-C and histone ChIP-seq data sets for the same 
tissue/cell types would help provide a clearer picture of the epigenetic landscape 
and facilitate identification of SOX3’s function at each binding region. Comparison 
with Sox3 null tissue will also help identify modifications that are SOX3 dependent, 
providing more information towards genomic regions where SOX3 is acting as a 
pioneer factor. These datasets would also provide more detailed information as to 
the state of each enhancer, if they are active or poised. It would also be interesting 
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to separate SSCs into GFRα1+ and GFRα1- populations (by FACS [251]) and 
comparing these profiles to identify what differences define the two populations. 
Changes in chromatin state and histone marks between the two similar cell 
populations will help identify differential use of enhancers and promoters, 
potentially providing the tools to pinpoint subtle changes required for the 




6.2 EXPLORING SOXB1 FUNCTIONAL REDUNDANCY  
 
SoxB1 functional redundancy has been discussed widely and is believed to provide 
a mechanism to ensure successful development of the CNS 
[74,89,93,94,107,119,189,252,253]. While functional redundancy may be important for 
minimising the damage caused by the loss or mutation of a family member, it 
creates a difficult scenario when it comes to identifying the specific role of an 
individual TF.  Our lab has investigated this functional redundancy in mice, through 
the replacement of the Sox3 ORF with the ORF of Sox2 [120]. The 5’ and 3’ UTRs 
were left untouched to ensure minimal disruption of any potential regulatory 
sequences. These Sox2 knock-in mice displayed an almost complete rescue of the 
Sox3 null phenotype, although some mild phenotypes remained. These include 
minor clefting of the adult pituitary, and small differences in gene expression in the 
testis [120]. Despite the altered gene expression, fertility was restored in these mice 
[120]. These residual phenotypes were minor and possibly due to slight reduction 
in the amount of SOX2 expressed from the Sox3 locus compared to WT SOX3 levels. 
Overall, these mice demonstrate that SOX2 can biochemically and functionally 
replace SOX3 in both the developing embryonic brain and the postnatal testis.  
We now know that SOX2 can replace SOX3 in terms of functional equivalence, 
which does not necessarily indicate that SOX3 (or another SOX TF) can replace 
SOX2. Niwa et al. 2016 demonstrated that SOX1 and SOX3 can restore pluripotency 
in ESCs that is lost when Sox2 is removed. They also established that replacing Sox2 
with Drosophila SoxN allows for the generation of chimeric mice, indicating some 
evolutionary conservation of SoxB1 and SoxN [119]. All cells in chimeric mice do not 
arise from the introduced genetically modified ESCs, and therefore does not 
completely address whether SOX2 can be completely replaced. As Sox3 is the 
founding member of the SoxB1 family, Sox1 and Sox2 arose from duplication events 
providing them with the ability to compensate for SOX3. Since their generation 
however, they may have gained additional functionality for which SOX3 may not 
be able to compensate.  
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Replacing the ORF of Sox2 with Sox3 (Sox2Sox3KI), using CRISPR/Cas9 and 
attempting to establish a colony of gene swapped mice would help address this 
question. As Sox2 null mice exhibit peri-implantation lethality, if SOX3 cannot 
compensate for SOX2 before implantation, no Sox2Sox3KI mice could be created. To 
verify and validate this finding, the one-step two-cell embryo microinjection 
method could be employed [254], injecting one cell of a two cell embryo, allowing 
the generation of chimeric mice. If these chimeric mice cannot be bred to create 
homozygous Sox2Sox3KI mice then this would indicate that SOX3 is not completely 
functionally redundant.   
It is interesting to note that whilst a majority of the SOX2 NPC peaks [55] are also 
bound by SOX3 [55,188], there’s a substantial number (13,954 peaks) of SOX3 only 
regions (181 SOX2+/SOX3- and 1,207 SOX2+/SOX3+ peaks [55]). Given the extent of 
the functional redundancy observed between SOX2 and SOX3, it could be expected 
that a majority of the peaks between the two sets would be shared. As SOX2 can 
bind both active and poised enhancers in addition to acting as a pioneer factor, just 
like SOX3, the number of identified binding sites appears low. The peaks identified 
by SOX2 ChIP-seq did not have central enrichment of a SOX motif. Together this 
suggests that the conditions, or the antibody used were suboptimal or unable to 
precipitate SOX2 in all of its functional states. Alternately, these are the real binding 
sites of SOX2 in NPCs (and ESCs) and SOX2 had developed a more refined 
mechanism of targeting DNA. Without further validation with an independent 
antibody it is impossible to draw any significant conclusions.  
While we know that functionally SOX2 can replace SOX3 in mice, it would be of 
interest to assess SOX2’s DNA binding profile in mouse testes. This comparison 
would be best performed using knock-in epitope tagged SOXB1 proteins, thus 
removing variability in ChIP experiments introduced through the use of two unique 
antibodies. ChIP-seq comparing tagged endogenous SOX3 with tagged Sox2Sox3KI 




6.3 FUNCTIONAL ANALYSIS OF SOX3 IN SPERMATOGONIA 
 
6.3.1 NON-SOX TF BINDING SITES WITHIN SOX3 CHIP-SEQ PEAKS 
Many of the SOX3 peaks featured binding sites of other TFs with known roles in 
spermatogenesis or mouse fertility. Co-localisation of SOX3 motifs with other TF 
motifs was rarely spaced close enough to imply direct binding partner interactions, 
however their presence help strengthen the argument that these regions are 
important for mouse fertility.  
The DMRT1 motif was found within 84 of the 778 peaks. Dmrt1 is expressed in the 
primordial gonads of embryonic mice at 10.5dpc. Dmrt1 expression increases in the 
testes as development progresses, and is maintained in Sertoli cells and 
spermatogonial stem cells [255-257]. DMRT1 has been shown to be required for 
maintaining and replenishing spermatogonia as stem cells, where the loss of Dmrt1 
leads to a decrease in PLZF and ultimately the differentiation of SSCs without 
replenishing the pool [258].  Overlapping phenotypes of Sox3 and Dmrt1 knockout 
mice supports the two genes sharing some targets. While there may be some 
overlap in terms of function, they cannot completely compensate for one another, 
as both Sox3 null and Dmrt1 null male mice are infertile [259]. 
Tead2 encodes a TF that plays a key role in the Hippo signaling pathway, 
regulating cell proliferation, migration as well as epithelial to mesenchymal 
transition [260]. Tead2 expression is restricted to Type A spermatogonia in the 
developing mouse testes, both early undifferentiated spermatogonia along with 
Sox3 as well as late stage undifferentiated spermatogonia [259]. Tead2 null mice 
do not show any obvious phenotype and have normal fertility [261]. It is thought 
that Tead1/Tead2 are functionally redundant as double knockouts are embryonic 
lethal (do not survive past 9.5dpc).  As a consequence, the fertility of Tead1/Tead2 
null mice has not been assessed and would require conditional deletion in the 
gonads [261]. 
Nr5a2 is expressed within spermatogonia. Nr5a2 null mice are embryonic lethal, 
and do not survive beyond 6.5dpc [262]. To date three different conditional 
knockout mice have been generated to assess the function of Nr5a2 in neural 
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development, T-cell function and ovarian development [263-265]. NR5A2 promotes 
neurogenesis through directly activating Prox1, leading to an inhibition of Notch 
signaling [263]. T-Cell specific deletion of Nr5a2 leads to a reduction in the number 
of mature T-Cells [264]. NR5A2 appears to have a broad role in many tissues, 
based on extensive cell-specific knockout data it would be likely that NR5A2 also 
plays an important role in spermatogenesis. Testes specific knockouts of Nr5a2 
(and Tead1/2), would help provide further evidence that these genes all belong to 
part of the same regulatory network or spermatogenesis related genes in the 
mouse testes.  
The enrichment of these DNA binding motifs of TFs expressed in the testes, within 
the SOX3 peaks identified by ChIP-seq, provides further evidence that these 
genomic regions are of importance during spermatogenesis. While it is unlikely that 
any of these TFs are direct binding partners in this context, they may still be 





6.3.2 NGN3 AND THE SPERMATOGENIC BLOCK IN SOX3 NULL MICE 
In Manuscript I and Manuscript II, we demonstrate that SOX3 binds upstream of 
Ngn3. Additionally we demonstrated that Ngn3 expression is decreased in Sox3 null 
testes, together demonstrating that Ngn3 is a direct target of SOX3.  We see that 
there appears to be two SOX3 regulatory regions in the promoter of Ngn3, one 
bound by SOX3 in NPCs and the other bound by SOX3 in testes. It would be 
interesting to assess the chromatin landscape of these regions in the two different 
cell populations as SOX3 binding at these regions may be controlled by chromatin 
modifications, or alternatively other proteins may be bound preventing SOX3s 
access depending on the cell type.  
Sox3 null mice exhibit a reduction in Ngn3 expression, starting off with a complete 
loss at P7 and returning to 70% WT levels by P28. Ngn3 expression has been shown 
to be controlled by other TFs expressed in spermatogonia, such as SOHLH1 and 
SOHLH2 which belong to the bHLH family of TFs. Similar to Sox3 null mice, a loss of 
Sohlh1 leads to a block in spermatogenesis and  a reduction in Ngn3 expression at 
P7 [266]. It is possible that both SOX3 and SOHLH1 act synergistically to initiate 
Ngn3 transcription, where the loss of just one of these TFs is sufficient to inhibit SSC 
differentiation. Individually, SOX3 or SOHLH1 may induce basal levels of Ngn3 






Figure 6.1. Model of Ngn3 expression in WT, Sox3 null and Sohlh1 null testes. 
Under normal conditions SOX3 and SOHLH1 may synergistically drive Ngn3 
expression in the testes, ensuring SSCs commit to differentiation and allow 
spermatogenesis to progress. In either Sox3 or Sohlh1 null mice Ngn3 expression is 
reduced dramatically, as the testes mature some SSCs may accumulate sufficient 




6.3.3 EPITOPE TAGGING NGN3 FOR MECHANISTIC INTERROGATION  
A significant hurdle preventing a complete understanding of the spermatogenesis 
pathway is the lack of a functional NGN3 antibody. To date there are no antibodies 
that reliably identify NGN3+ cells via immunohistochemistry. Although there are 
published data suggesting an NGN3 antibody is functional [108], these results have 
yet to be repeated successfully. While there is an NGN3/GFP reporter strain, this 
does not provide direct information regarding endogenous NGN3 expression, 
protein half-life or function. To overcome this, it is now significantly easier to tag 
endogenous genes [267], such as NGN3, utilizing the CRISPR/Cas9 genome editing 
system. Once tagged, identifying NGN3+ cells will no longer be an issue. Tagged 
NGN3 would allow for the identification of which cells express NGN3 and at which 
stage in spermatogenesis, when NGN3 expression is turned on/off, what other 
markers NGN3+ cells also express. Protein and transcript data for NGN3 can be 
combined and used to tease apart the recovery of spermatogenesis that Sox3 null 
mice exhibit.   
Aside from allowing us to be certain of the cells expressing NGN3, epitope tagging 
the endogenous NGN3 will also provide the ability to perform ChIP-Seq on NGN3. 
NGN3 is a basic helix-loop-helix (bHLH) TF, as identified by sequence homology 
within the bHLH domain [268-270]. However, with no useful antibodies developed 
against NGN3 understanding its mode of action is limited to knockout studies. ChIP-
Seq against NGN3 would help identify which genes and transcriptional pathways 





6.3.4 IDENTIFYING THE PATHWAY LEADING TO INCREASED GFRΑ1+ CELLS IN 
SOX3 NULL MICE 
In Manuscript I, we identified an increase in the number of GFRα1+ spermatogonia 
in P7 Sox3 null mouse testis. SOX3 is required for the successful transition of early 
(GFRα1+/NGN3-) to late (GFRα1-/NGN3+) committed spermatogonia. We proposed 
that in Sox3 null mouse testis, type A spermatogonia revert back from a late 
committed state (GFRα1-) to an early committed state (GFRα1+) after failing to 
express SOX3. This hypothesis could be confirmed through a fate mapping 
experiment.  
Our model suggests that two distinct populations of GFRα1+ spermatogonia exist, 
those that have not attempted to switch on Sox3 expression, and those that have 
attempted (but failed) to switch on Sox3 expression. A Rosa26 Flox-STOP-Flox-LacZ 
reporter mouse strain can be crossed with Sox3 null mice expressing Cre 
recombinase under the control of the Sox3 promoter. Cells that attempt to express 
Sox3 will instead express CRE, which will remove the stop codon in front of LacZ, in 
turn allowing the expression of LacZ. Immunohistochemical analysis of the testes 
(looking for GFRα1, LACZ and GFP) would provide evidence towards the mechanism 
behind the spermatogenic block. The presence of GFRα1+/LacZ+/GFP- 





6.3.5 OVERCOMING THE SPERMATOGENIC BLOCK IN SOX3 NULL MICE 
We know that the spermatogenic block in Sox3 null mice is more severe on a pure 
inbred strain, such as C57BL/6J or 129/SvJ, compared to a mixed background. The 
ability to overcome this block may be caused by subtle differences in mouse 
strains, such as modifier genes [271,272], epigenetic modifications [272] and/or 
hormonal expression and responses [273,274]. Modifier genes are genetic variants 
that lead to a change phenotype at an independent locus, and can have subtle or 
profound effects [271].  It would be interesting to investigate what is causing this 
phenotypic rescue in mixed background Sox3 null mice.   
Pituitary gonadotropins follicle-stimulating hormone (FSH) and luteinising hormone 
(LH) are both required to initiate spermatogenesis. In their absence, 
spermatogenesis cannot initiate and spermatogonia remain in their 
undifferentiated state [275]. Although FSH and LH levels are normal in Sox3 null 
mice [108], spermatogonia may still respond to increasing hormone levels within 
the testes and initiate differentiation. Gonadotropin or testosterone could be 
injected into juvenile mouse testes at regular intervals for a number of months 
before assessing sperm production. If sperm production is restored in Sox3 null 
mice on a C57BL/6J mice then this would suggest that hormone response may be 




6.3.6 SOX3 MAY HAVE A SIMILAR ROLE IN SSCS AND OPCS  
SOX3 functions in NPCs to maintain progenitor like state, while in SPCs SOX3 is 
required to complete the transition from early to late committed progenitor cells. 
While the function of SOX3 appears to be different between NPCs and SSCs, SOX3’s 
role in SSCs and oligodendroglial progenitor cells (OPCs) may be similar. As 
mentioned earlier, SOX3 acts as a differentiation factor in OPCs, and its absence 
leads to fewer terminally differentiated oligodendrocytes [96]. Given the similar 
function for SOX3 between these two cell types it would be interesting to compare 
ChIP-seq of SOX3 and SOX2 in OPCs and SSCs. There are current culture methods 
allowing for the culture of OPCs from ESCs by culturing ESC-derived embryoid 
bodies in defined media containing retinoic acid and purmorphamine, resulting in 
an 80% pure OPC population [276]. The comparison of SOX3 ChIP-Seq between the 
two cell types would highlight any common genes and regulatory regions that 
SOX3 uses to promote progenitor cell differentiation. Adding in SOX2 ChIP-seq 
would expand on the functional redundancy mechanisms but in a different cell 




6.3.7 EVIDENCE OF HUMAN INFERTILITY CAUSED BY SOX3 MUTATIONS 
As described above, Sox3 null mice exhibit both brain and fertility defects. 
Predictably, these phenotypes exist within Sox3 expressing regions within the 
mouse. While Sox3 null mice exhibit fertility defects, this phenotype has not yet been 
linked with mutations in human SOX3.  Stevanovic et al. 1993 identified a male 
patient with a deletion encompassing SOX3 (and two other males from the same 
pedigree) exhibiting partial primary testicular failure [133]. However, it was 
concluded that SOX3 was not required for human testis formation as the testes still 
partially developed. However, in mice we still see the formation of testes, albeit 
empty. These SOX3 deletion patients showed a reduction in endocrine function, 
however a sperm count was not reported [133]. It is still possible that these men had 
reduced sperm production caused by the loss of SOX3. Given current knowledge, 
assessing SOX3 deletion patients for mature sperm production would help link 
SOX3 to spermatogenesis in humans. While it is common for congenital pituitary 
hormone deficiencies to result in infertility [277], there have been no reported cases 
of impaired fertility in patients XH caused by mutations in SOX3 [122].  
Raverot et al. 2004 screened 56 human males with idiopathic oligoazoospermic 
infertility for mutations in SOX3. Only 3 were found to have a single polymorphic 
variants within the coding region, which lead to synonymous amino acid changes 
[278]. It is possible that screening larger cohorts of infertile, or even sub-fertile, men 
may lead to the identification of additional causative SOX3 mutations. Sox3 null 
mice have been shown to be able to overcome the spermatogenic block, 
depending on the genetic background of the mouse, it is possible that humans can 
overcome this block as well (if a block even occurs). Mice on a mixed background 
are less affected by the block in spermatogenesis, it is possible that the increased 
genetic diversity these mice feature, compared to an inbred strain, provides the 
ability to minimise genetic defects. Humans exhibit significant amounts of genetic 
diversity which define and modify their response to a range of challenges including 
chemical exposures and genetic abnormalities [279,280]. This genetic variation 
observed in humans may be sufficient to mitigate some genetic phenotypes, such 
as the spermatogenic block observed in Sox3 null mice [281]. Alternatively, given 
the rapid evolution of reproductive genes [224-226], SOX3 may not play the same 
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role in human spermatogonia that it does in mice and therefore mutations in SOX3 




6.4 COMPARSION OF SOX3 IN TWO DIFFERENT TISSUES 
 
6.4.1 SOX3 BINDS TEX14 IN NPCS AND POSTNATAL TESTES 
The SOX/POU DNA binding motif was observed in 65/218 peaks common to both 
NPC and testes datasets. Two of these peaks were identified within the cluster of 
peaks surrounding the first exon of the predominant Tex14 transcript. Previously, 
we proposed that Tex14 may belong to a large transcriptional hub in NPCs [188]. 
Tex14 is essential for spermatogenesis and Tex14 null mice are infertile due to the 
inability of germ cells to form intercellular bridges [282]. Similar to Sox3 null mice, 
the testis of Tex14 null mice are smaller, and lack mature sperm [283]. However, 
unlike Sox3 null testis, Tex14 male mice do not overcome this block in 
spermatogenesis [283]. Tex14 was not observed to be downregulated in Sox3 null 
testes [120]. This does not rule SOX3 out as being a direct regulator of Tex14, as 
there may be redundant mechanisms in place to maintain Tex14 expression in the 
absence of SOX3. The microarray analysis was performed at P14, 7 days later than 
this ChIP-seq experiment. It would be interesting to profile the expression of Tex14 
in WT and Sox3 null testes across a range of time points to see if there is any 
observable change in gene expression. The similarity in phenotypes observed, and 
the lack of recovery of spermatogenesis, indicates that SOX3 likely acts upstream 
of Tex14. The loss SOX3 can be compensated for, allowing for the partial rescue of 
spermatogenesis.  
We have identified 6 SOX3 binding sites around the promoter of Tex14 in both NPCs 
and testes. To date, Tex14 expression has not been shown in the embryonic or adult 
mouse brain, and no neural phenotype has been described in the Tex14 null mouse 
model. Our NPC microarray data shows Tex14 is expressed in NPCs [189], however 
gene expression does not change following the loss of Sox3, much like in the testes. 
Considering multiple isoforms of Tex14 exist, it is possible that subtle changes in the 
expression of individual isoforms have been missed by microarray. To overcome 
this, isoform specific primers could be developed to asses Tex14 expression by 
qPCR. Thus, there is mounting evidence that SOX3 regulates Tex14 in two different 
cell types, although additional functional experiments are required to clarify this 
connection.   
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6.4.2 NGN3: ONE GENE, TWO DISTINCT SOX3 REGULATORY REGIONS 
Another gene that may be regulated by SOX3, is Ngn3, which encodes a basic Helix 
Loop Helix TF, and known mostly for its role in the differentiation of endocrine cells 
and NPCs [284,285]. Ngn3 mirrors the expression pattern of SOX3 during early 
spermatogenesis, being found in As, Apr and Aal spermatogonia [160,190], and its 
expression is abolished in Sox3 null mice [108]. This, coupled with the fact that other 
members of the SOXB1 family are known to regulate the expression of other 
Neurogenin members during neuronal differentiation [286], led Raverot and 
colleagues (2005) to propose a functional link between SOX3 and NGN3 in the 
differentiation of spermatogonia. In the microarray data of Sox3 null testes [120], 
its expression was reduced to 50% of normal levels. This reduced expression 
indicates a strong reliance on SOX3, either through direct regulation or through an 
indirect signaling pathway involving SOX3, or both. We have identified two different 
SOX3 bound regions within the promoter of Ngn3, one found only in testes, and one 
found only in NPCs. These two different regions may indicate SOX3 uses two unique 
binding sites to regulate the expression of Ngn3 depending on cellular context. 
Control of these two binding sites may be provided by different combinations of 
binding partners, or different chromatin states, however further experimentation 
would be required. In silico analyses comparing the two binding regions could look 
for evolutionarily conserved partner binding sites to identify potential control 
binding sites.  
Examination of the region upstream of the Ngn3 promoter indicates two distinct 
highly conserved regions, each containing one of the two SOX3 bound sites. It would 
be interesting to assess whether either of these regions can act as enhancers 
through use of a reporter assay. Each highly conserved region could be used to 
drive the expression of a LacZ reporter system. Different cell types could be used 
to provide further information as to the cellular context in which these putative 
enhancers may be functional (eg NPCs and telomerase-immortalized mouse type 
A spermatogonial cells). Comprehensive ChIP profiling of the Ngn3 promoter region 
for TFs including OCT4 can help tease apart what other TFs/cofactors are required 




6.4.3 SOX3 MAY REGULATE HISTONE EXPRESSION IN NPCS AND SPCS 
During the process of cell replication, genomic DNA is duplicated requiring large 
numbers of de novo histones (H1, H2A & H2B, H3 and H4) which are integrated into 
and help compact the newly synthesized DNA [287]. Histone expression can control 
the rate of replication, if there are insufficient histones within the cell the replication 
rate is decreased and can ultimately cause premature exit from the cell cycle [287]. 
Regulation of core histones is not reliant on single transcriptional mechanisms, 
rather multiple redundant mechanisms exist to ensure the continuous and 
appropriate supply of new histones when required [288,289].  
In Paper I and Manuscript II we found that SOX3 at the promoters of a large number 
of histone gene variants, and chromatin modifier genes in both NPCs and postnatal 
testes. SOX3 has not previously been reported to regulate histone gene expression. 
However there is mounting evidence that SOX3 may be involved in cell cycle 
regulation. SOXB1 TFs have been shown to help maintain neural cells in a progenitor 
like state, and functionally act to repress PROX1-mediated cell cycle exit and 
neurogenesis [59,290]. SOX3 binding at histone promoters may be indicative of a 
novel cell cycle control mechanism, in addition to the PROX1 pathway.  
Differential expression has not been reported in histone genes when comparing WT 
and Sox3 null tissues. Ultimately it is not histone RNA levels that control cell cycle 
exit, rather, histone protein levels. Quantitative histone analyses could be used to 
investigate whether changes in histone protein levels exist between WT and Sox3 
null SSCs or NPCs. Methods such as HiHiMap could be employed, where cells are 
incubated with DAPI, anti-CyclinA, anti-Histone of interest antibodies, the 
fluorescent intensities are used to quantitate histone levels [291]. Differences in 
total histone protein proportions within SSCs would imply SOX3 plays a critical role 
in histone protein regulation.  
This proposed core role of SOX3 is based on preliminary DNA binding data, further 
investigation is required to confirm or disprove this hypothesis. Upon confirmation 
of SOX3 binding at the promoters of these histones in a greater number of samples, 
functional assays would be required to identify SOX3’s function at these promoters. 
To date SOX3’s ability to influence the cell cycle has not been addressed in mouse 
cells/tissues. The ability of WT and Sox3 null NPCs/SSCs to navigate and progress 
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through the cell cycle could be compared using a variety of cell cycle markers, 
looking for premature exit of the cell cycle in Sox3 null cells.  
Throughout spermatogenesis, SSCs undergo a large number of changes, including 
cell morphology, nuclear compaction, and ploidy level, as they differentiate and 
form mature sperm. Mature sperm do not contain regular histones - they are 
swapped out for protamines, allowing for increased levels of nuclear compaction. 
This process of swapping histones for protamines proceeds through transitional 
phases that utilize testes-specific histone variants. It is possible that in SSCs, SOX3 




6.5 CONCLUDING REMARKS 
 
The experiments and data produced during the course of this PhD have led to the 
generation of two unique SOX3 ChIP-Seq data sets in two different SOX3+ cell 
populations/tissues. We have identified a number of evolutionary conserved 
enhancers in NPCs, as well as refining a list of potential base transcriptional targets 
that may be common to SOX3+ cells regardless of cell type. Aside from the greater 
understanding of how SOX3 functions, we have developed two large ChIP-seq data 
sets which will be useful for us and other researchers in years to come.  
We have narrowed down the specific sub population of spermatogonial cells that 
express SOX3, helping us understand the function of SOX3 in spermatogonia. We 
have highlighted potential pathways that likely include Ngn3 by which SOX3 
maintains spermatogonia in an uncommitted progenitor state. Further studies are 
required to reveal the complete mechanisms that drive stem cells into committed 
precursors. CRISPR/Cas9 genome editing tools will likely play a key role in teasing 
apart this mechanism.  
Additionally, we have identified a number of targets of SOX3 common to both NPCs 
and SSCs. The majority of these sites are at the promoters of histones or chromatin 
related genes. This may indicate the existence of a novel core function for SOX3 
relating to chromatin regulation, regardless of cell type.  
Together these data help shape our knowledge of SOX3 transcriptional targets and 
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